<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63003</article-id><article-id pub-id-type="doi">10.7554/eLife.63003</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Short-term exposure to intermittent hypoxia leads to changes in gene expression seen in chronic pulmonary disease</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-208467"><name><surname>Wu</surname><given-names>Gang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4526-2034</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-208468"><name><surname>Lee</surname><given-names>Yin Yeng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8092-3926</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208469"><name><surname>Gulla</surname><given-names>Evelyn M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208470"><name><surname>Potter</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208471"><name><surname>Kitzmiller</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208472"><name><surname>Ruben</surname><given-names>Marc D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-133155"><name><surname>Salomonis</surname><given-names>Nathan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-70043"><name><surname>Whitsett</surname><given-names>Jeffery A</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208473"><name><surname>Francey</surname><given-names>Lauren J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-138632"><name><surname>Hogenesch</surname><given-names>John B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-206537"><name><surname>Smith</surname><given-names>David F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0048-4012</contrib-id><email>david.smith3@cchmc.org</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Divisions of Human Genetics and Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Division of Pediatric Otolaryngology - Head and Neck Surgery, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Division of Pulmonary Medicine and the Sleep Center, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>The Center for Circadian Medicine, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution>Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Agrawal</surname><given-names>Anurag</given-names></name><role>Reviewing Editor</role><aff><institution>CSIR Institute of Genomics and Integrative Biology</institution><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kaeberlein</surname><given-names>Matt</given-names></name><role>Senior Editor</role><aff><institution>University of Washington</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>02</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e63003</elocation-id><history><date date-type="received" iso-8601-date="2020-09-11"><day>11</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-17"><day>17</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Wu et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Wu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63003-v3.pdf"/><abstract><p>Obstructive sleep apnea (OSA) results from episodes of airway collapse and intermittent hypoxia (IH) and is associated with a host of health complications. Although the lung is the first organ to sense changes in oxygen levels, little is known about the consequences of IH to the lung hypoxia-inducible factor-responsive pathways. We hypothesized that exposure to IH would lead to cell-specific up- and downregulation of diverse expression pathways. We identified changes in circadian and immune pathways in lungs from mice exposed to IH. Among all cell types, endothelial cells showed the most prominent transcriptional changes. Upregulated genes in myofibroblast cells were enriched for genes associated with pulmonary hypertension and included targets of several drugs currently used to treat chronic pulmonary diseases. A better understanding of the pathophysiologic mechanisms underlying diseases associated with OSA could improve our therapeutic approaches, directing therapies to the most relevant cells and molecular pathways.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>obstructive sleep apnea</kwd><kwd>single cell sequencing</kwd><kwd>intermittent hypoxia</kwd><kwd>lung</kwd><kwd>RNA sequencing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5K08HL148551-02</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David F</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010836</institution-id><institution>American Laryngological, Rhinological and Otological Society</institution></institution-wrap></funding-source><award-id>2017 Career Development Award</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David F</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010475</institution-id><institution>American Society of Pediatric Otolaryngology</institution></institution-wrap></funding-source><award-id>2016 Basic Research Award</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David F</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007172</institution-id><institution>Cincinnati Children's Hospital Medical Center</institution></institution-wrap></funding-source><award-id>Procter Scholar Award</award-id><principal-award-recipient><name><surname>Smith</surname><given-names>David F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>RNA profiles from lungs of mice exposed to intermittent hypoxia shared similarity with gene expression changes in human lung from patients with pulmonary diseases, including pulmonary hypertension, COPD, and asthma.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Obstructive sleep apnea (OSA) is a condition characterized by episodes of sleep-associated upper airway obstruction and intermittent hypoxia (IH). OSA occurs in approximately 2–5% of children (<xref ref-type="bibr" rid="bib71">Marcus et al., 2012</xref>) and 33% of adults 30–69 years of age (<xref ref-type="bibr" rid="bib7">Benjafield et al., 2019</xref>) in the USA. If untreated, OSA is associated with significant health consequences to the cardiovascular, neurological, and metabolic systems. Even young children with moderate to severe OSA can develop blood pressure dysregulation (<xref ref-type="bibr" rid="bib4">Amin et al., 2004</xref>), systemic hypertension (<xref ref-type="bibr" rid="bib27">Enright et al., 2003</xref>; <xref ref-type="bibr" rid="bib56">Kohyama et al., 2003</xref>), and left ventricular hypertrophy (<xref ref-type="bibr" rid="bib3">Amin et al., 2002</xref>; <xref ref-type="bibr" rid="bib5">Amin et al., 2005</xref>). OSA is associated with a significant socioeconomic burden in the USA (<xref ref-type="bibr" rid="bib100">Sullivan, 2016</xref>). Despite available medical and surgical therapies, millions of children and adults with OSA are currently untreated or do not respond to available therapies. Cellular responses to changes in oxygen levels are primarily mediated by the hypoxia-inducible factors (HIFs). Although the lung is the first organ to sense large changes in inspired oxygen levels, little is known about the consequences of IH to the lung HIF-responsive pathways. Without a basic understanding of the molecular mechanisms that lead to diseases associated with IH and OSA, our ability to identify new treatments is significantly hindered.</p><p>Efforts to understand the effects of OSA have primarily focused on systemic inflammation (<xref ref-type="bibr" rid="bib38">Gozal et al., 2008</xref>), oxidative stress (<xref ref-type="bibr" rid="bib103">Tauman et al., 2014</xref>), and endothelial dysfunction (<xref ref-type="bibr" rid="bib52">Kheirandish-Gozal et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Bhattacharjee et al., 2012</xref>). However, the early causal events from IH exposure are not fully elucidated. Research is now focused on other possible pathogenic pathways that could be activated or suppressed in the presence of IH, leading to disease. For example, HIFs stabilized under low-oxygen conditions can affect the circadian transcriptional–translational feedback loop at the cellular level (<xref ref-type="bibr" rid="bib1">Adamovich et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Kobayashi et al., 2017</xref>; <xref ref-type="bibr" rid="bib82">Peek et al., 2017</xref>; <xref ref-type="bibr" rid="bib117">Wu et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Hogenesch et al., 1998</xref>). Even acute exposure to IH results in dysregulation of the circadian clock that is time-of-day dependent and tissue specific, and these effects persist in some tissue for up to 24 hr after exposure (<xref ref-type="bibr" rid="bib70">Manella et al., 2020</xref>). Pathways involved in immune responses and regulation can also be activated or suppressed in the presence of IH (<xref ref-type="bibr" rid="bib19">Cubillos-Zapata et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Lam and Ip, 2019</xref>), contributing to comorbid disease initiation and progression. Associations between IH and gene targets could be either pathogenic or protective responses for the lung. Additionally, the lung could be an effector rather than the target organ of IH, resulting in responses to IH that lead to multi-systemic effects.</p><p>While animal models of OSA have focused on physiologic responses to IH at organ and system levels, the determination of the contributions of individual cell types in the initiation and progression of disease has been challenging. Within organs, individual cells serve specific physiologic roles. As a result, pathways disrupted by stabilization of HIFs can affect cell types differently. Single-cell RNA sequencing (scRNA-seq) has emerged as a method for evaluating transcriptional states from thousands of individual cells (<xref ref-type="bibr" rid="bib123">Zhang et al., 2018</xref>), advancing our understanding of how specific cell types contribute to physiology and disease (<xref ref-type="bibr" rid="bib123">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Plasschaert et al., 2018</xref>).</p><p>In the present study, we used IH as a mouse model of OSA to better understand early cellular-specific consequences to the lung, the primary organ that first senses hypoxic episodes. We hypothesized that exposure to IH would lead to up- and downregulation of diverse expression pathways, that distinct cell populations would show distinctive responses to IH, and that changes in these gene expression pathways could provide therapeutic targets at the cell-specific level. We identify changes in both circadian and immune response pathways in lungs from mice exposed to IH. We also demonstrate strong similarities in the gene expression profiles from mice compared to those characteristics of human lung tissue from patients with diverse pulmonary diseases, including pulmonary hypertension and pulmonary fibrosis. Our results reveal potential candidates for cell-targeted therapy seeking to minimize effector responses of the lung that could lead to systemic disease. A better understanding of the pathophysiologic mechanisms underlying diseases associated with OSA could improve our therapeutic approaches.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Short-term exposure to IH reshapes circadian and immune pathways in the lung</title><p>In humans, moderate to severe OSA is associated with interstitial lung disease with remodeling of the extracellular matrix (<xref ref-type="bibr" rid="bib53">Kim et al., 2017</xref>). Lung is the primary organ that senses episodes of hypoxia and is therefore exposed to large fluctuations in the oxygen concentrations compared to other tissues throughout the body. For these reasons, we sought to identify initial changes in gene expression pathways in the lung in response to IH.</p><p>Mice were initially entrained to the same light:dark schedule to synchronize active and inactive phases. After 14 days of entrainment in the 12 hr:12 hr light:dark cycle, mice were exposed to IH or room air (normoxia) for the entire 12 hr inactive phase for 9 days (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Hematoxylin and eosin (H and E) staining of whole lungs did not show comprehensive changes in architecture or inflammatory remodeling after exposure to IH (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Bulk RNA sequencing (Bulk RNA-seq) was performed to explore transcriptomic effects of IH on lung tissue at the organ level. There were 374 genes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>) upregulated and 149 downregulated in mouse lung after exposure to IH (Benjamini-Hochberg q value (BHQ) &lt; 0.05 and fold change &gt; 1.5). Not surprisingly, the top upregulated genes included well-known HIF-1 target genes (e.g. <italic>Edn1</italic>, <italic>Bnip3</italic>, and <italic>Ankrd37</italic>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Short-term exposure to intermittent hypoxia reshapes circadian and immune pathways in the lung.</title><p>(<bold>A</bold>) Schematic of IH protocol. Mice are entrained to the same 12 hr:12 hr light:dark cycle for 14 days prior to IH exposure. Mice are exposed to normoxia (controls) or intermittent episodes of hypoxia (21–6% oxygen saturation) followed by recovery to 21% oxygen over the entire 12 hr inactivity phase for 9 days. Mice are then sacrificed at ZT 3 (3 h after lights-on) on the 10th day for tissue harvest. Bulk RNA-seq and scRNA-seq were performed for each group. (<bold>B</bold>) Biological processes enriched in lung from mice exposed to IH vs controls. Enrichment analysis was performed in the DAVID database, using the top 200 up- and downregulated genes identified from differential expression analyses. Redundant biological processes are merged into one category. Biological processes enriched in up- and downregulated genes are indicated in red and blue bars, respectively. (<bold>C</bold>) The heatmap shows the fold change of associated genes in circadian rhythm, response to hypoxia, and immune response. The red and blue indicate up- and downregulated genes in the experimental group. There are six biological replicates for each group.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig1">Figure 1B,C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig1-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Hematoxylin and eosin (HE)-stained sections of whole lung from mice exposed to IH vs controls do not reveal comprehensive histologic changes.</title><p>Two representative IH and two control mice with HE-stained sections were shown at 4× (<bold>A–D</bold>), 10× (<bold>E–H</bold>), and 20× (<bold>I–L</bold>) magnification. The scale bars all correlate to 100 µm width.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Differentially expressed genes from bulk RNA-seq analysis of whole lung from mice exposed to IH vs controls.</title><p>(<bold>A</bold>) At series BHQ cutoffs, the number of up- and downregulated genes in response to IH are shown with red and blue lines, respectively. (<bold>B</bold>) A volcano plot shows the differentially expressed genes from lung of mice exposed to IH. Ranked by p-value, top 20 upregulated genes and top 10 downregulated genes were labeled.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig1-figsupp2-v3.tif"/></fig></fig-group><p>We performed DAVID (<xref ref-type="bibr" rid="bib47">Huang et al., 2009</xref>) enrichment analysis to identify biological processes associated with the top 200 up- and downregulated genes from mice exposed to IH. Pathways induced in response to hypoxia included circadian rhythm, angiogenesis, and extracellular matrix organization (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>). As previously reported, there is a tight interaction between clock genes and HIFs (<xref ref-type="bibr" rid="bib25">Edgar et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Gu et al., 2000</xref>; <xref ref-type="bibr" rid="bib46">Hogenesch et al., 1998</xref>; <xref ref-type="bibr" rid="bib73">McIntosh et al., 2010</xref>; <xref ref-type="bibr" rid="bib105">Taylor and Zhulin, 1999</xref>). Several circadian clock repressors (e.g. <italic>Nr1d1</italic>, <italic>Nr1d2</italic>, <italic>Bhlhe40</italic>, and <italic>Per3</italic>) were significantly upregulated in the IH group (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Increased expression of RNAs associated with angiogenesis, such as vascular endothelial growth factor (VEGF), was observed after IH, consistent with findings in a mouse model of prolonged exposure to IH (<xref ref-type="bibr" rid="bib88">Reinke et al., 2011a</xref>) and after 72 hr of IH exposure to endothelial cells in vitro (<xref ref-type="bibr" rid="bib116">Wohlrab et al., 2018</xref>). There is a tight relationship between angiogenesis and pulmonary hypertension (<xref ref-type="bibr" rid="bib108">Tuder and Voelkel, 2002</xref>), a clinical consequence associated with OSA. Unexpectedly, RNAs associated with immune responses and cell cycle were significantly downregulated after 9 days of IH (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>). Present findings contrast with the general concept that HIFs are important regulators of inflammation and immune responses (<xref ref-type="bibr" rid="bib26">Eltzschig and Carmeliet, 2011</xref>; <xref ref-type="bibr" rid="bib92">Scholz and Taylor, 2013</xref>; <xref ref-type="bibr" rid="bib104">Taylor et al., 2016</xref>). For example, activation of neutrophils by HIFs is largely considered proinflammatory (<xref ref-type="bibr" rid="bib114">Walmsley et al., 2005</xref>; <xref ref-type="bibr" rid="bib84">Peyssonnaux et al., 2005</xref>; <xref ref-type="bibr" rid="bib104">Taylor et al., 2016</xref>). The cell cycle and cell division downregulation may be associated with HIFs induced in cell cycle arrest in response to IH (<xref ref-type="bibr" rid="bib58">Koshiji et al., 2004</xref>).</p></sec><sec id="s2-2"><title>Single-cell sequencing identifies 19 distinct cell types in the lungs of IH and control mice</title><p>We detected significant differences related to a number of biological functions at the tissue level. We then applied single-cell transcriptomics to identify cell type-specific effects of IH. We performed three biological replicates in each group to improve the statistical power in differential gene expression analysis at the single cell level. In total, we sequenced 12,324 and 16,125 pulmonary cells from IH and control mice, with 3542–5641 cells per biological replicate. Unsupervised analysis identified 25 transcriptionally distinct cell clusters, corresponding to 19 distinct cell types (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>) based on the expression of established marker genes (see Materials and methods), including stromal, epithelial, endothelial, immune, and small numbers of other cell types. In brief, AltAnalyze identified 40–60 marker genes for each cell cluster. We annotated each cluster to a cell type using enrichment analysis between these marker genes and a comprehensive reference marker gene list, which is collected from public databases and published scRNA-seq studies performed in mouse or human lungs. As shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, the cell-type assignment was also validated with multiple well-known cell-type markers. The proportion of endothelial, alveolar epithelial type II (AT2), and fibroblast/myofibroblast cells were modestly increased, but the proportion of immune cells (e.g. B and T cells) was decreased in the IH-exposed mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Overall, the proportional variation of lung cell types was small (BHQ &gt; 0.05). We further performed confocal immunofluorescence to evaluate variation in lung structure and to quantify the differences in cell number of major cell types in mice exposed to IH compared to controls.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Single-cell sequencing identifies 19 distinct cell types in the lungs of intermittent hypoxia and control mice.</title><p>(<bold>A</bold>) Heat map of AltAnalyze selected marker genes for each cell population. Columns and rows represent individual cells and marker genes, respectively. Biological replicates and cell types are indicated by the color bars on the top. cellHarmony was used to align cells from control to IH groups. (<bold>B</bold>) UMAP projection of whole lung cell populations from IH and control mice in the heatmap. (<bold>C</bold>) Expression of marker genes for each cell type from experimental and control mice. Error bars indicate standard deviation of cell proportion from the three replicates. The list of cell types include endothelial cells (Endo), B cells (Bcells), natural killer cells (NK), T cells (Tcells), natural killer T cells (NK-T), macrophages (Mphage), basophils (Baso), monocytes (Mono), macrophages-dendritic CD163<sup>+</sup> cells (Mphage-DC), dendritic cells (DC), megakaryocytes (MegK), fibroblasts (FB), myofibroblasts (MyoFB), pericytes (Pcyte), alveolar epithelial type I cells (AT1), lymphatic endothelial cells (LymEndo), erythroblasts (Erythro), alveolar epithelial type II cells (AT2), and ciliated cells (Ciliated). CPM indicates UMI count per million.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig2-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Percentage of detected lung cell types from mice exposed to IH vs controls.</title><p>(<bold>A</bold>) Percentage of each cell type from experimental and control mice. Error bars indicate standard deviation of cell proportion from the three biological replicates. The list of cell types include: endothelial cells (Endo), B cells (Bcells), natural killer cells (NK), T cells (Tcells), natural killer T cells (NK-T), macrophages (Mphage), basophils (Baso), monocytes (Mono), macrophages-dendritic CD163+ cells (Mphage-DC), dendritic cells (DC), megakaryocytes (MegK), fibroblasts (FB), myofibroblasts (MyoFB), pericytes (Pcyte), alveolar epithelial type I cells (AT1), lymphatic endothelial cells (LymEndo), erythroblasts (Erythro), alveolar epithelial type II cells (AT2), and ciliated cells (Ciliated).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig2-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Short-term exposure to IH did not lead to comprehensive histologic changes in the lung</title><p>Similar to H and E histology, confocal immunofluorescence microscopy did not demonstrate comprehensive inflammatory remodeling. However, some modest changes were noted with specific cell populations. Immunostaining for endothelial markers FOXF1 and LYVE1 showed modest increases in the number of endothelial cells in mice exposed to IH (<xref ref-type="fig" rid="fig3">Figure 3C,D</xref>) compared to control mice (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>). Also important, staining for MKI67 did not show statistically significant changes in cell proliferation (<xref ref-type="fig" rid="fig3">Figure 3E–H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Expression levels of HOPX and SFTPC in alveolar type I and II cells, respectively, were not different for IH (<xref ref-type="fig" rid="fig3">Figure 3K,L</xref>) versus control (<xref ref-type="fig" rid="fig3">Figure 3I,J</xref>) mice. The trend for small increases in AT2 cells, although not significant, was also seen from the scRNA-seq data (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Immunostaining for the progenitor marker SOX9 (<xref ref-type="fig" rid="fig3">Figure 3I–L</xref>) or the extracellular matrix marker POSTN (<xref ref-type="fig" rid="fig3">Figure 3M–P</xref>) did not demonstrate any significant changes after IH exposure. Overall, there was a modest increase (11.5%; BHQ &lt; 0.05) of endothelial cells in mice exposed to IH compared to controls (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>); however, this does not necessarily reflect a biologic difference. This trend for an increasing number of endothelial cells in the histologic samples was similar to the changes in cell numbers seen from the scRNA-seq data (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Other cell percentages, including AT2 cells and proliferating cells, were not significantly different between IH and control groups. We did not see comprehensive changes in alveolar area and alveolar wall thickness based on morphometric quantification for mice exposed to IH compared to controls (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–C</xref>). The average MaxFeret90 measurements and alveolar areas were 21.0 µM and 419 µM<sup>2</sup> in mice exposed to IH, while the average MaxFeret90 measurements and alveolar areas were 23.5 µM and 564 µM<sup>2</sup> in control mice. The mean alveolar wall thickness was 4.81 µM for mice exposed to IH and controls.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Short-term exposure to intermittent hypoxia did not lead to comprehensive histologic changes in the lung.</title><p>(<bold>A–D</bold>) Immunostaining for LYVE1, FOXF1, and ACTA2: LYVE1 is expressed at high levels in lymphatic and vascular endothelial cells. FOXF1 and ACTA2 are expressed at high levels in vascular endothelial and smooth muscle cells, respectively. (<bold>E–H</bold>) Immunostaining for MKI67, FOXF1, and Pro-SFTPC: MKI67 is a marker for cell proliferation. Pro-SFTPC shows high expression levels in alveolar epithelial type II cells. (<bold>I–L</bold>) Expression levels of SOX9, HOPX, and Pro-SFTPC: SOX9 is a marker for progenitor cells. HOPX shows high expression levels in the alveolar epithelial type I cells. (<bold>M–P</bold>) Immunostaining for POSTN, EMCN, and ACTA2: POSTN is used to stain extracellular matrix. EMCN is a marker for capillaries and veins/venules. The scale bars for (<bold>A</bold>–<bold>D</bold>) represent 100 µm. The scale bars for (<bold>E</bold>–<bold>P</bold>) represent 40 µm.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref> and <xref ref-type="fig" rid="fig3s2">2</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig3-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>The cell percentages for endothelial, AT2, and proliferating cells in mice lung exposed to IH vs controls.</title><p>The cell counts are quantified from confocal images. Error bars indicate standard deviation of cell proportion from four biological replicates per group. *BHQ &lt; 0.05; NS, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig3-figsupp1-v3.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Alveolar area and alveolar wall thickness are quantified from confocal images for mice exposed to IH compared to controls.</title><p>MaxFeret90 (<bold>A</bold>) and alveolar areas (<bold>B</bold>) are quantified in Nikon Elements. Maxferet90 is the distance measured orthogonally to the maximum feret chord. The higher Maxferet90 value indicates larger space in the alveolus. N = 2 mice for controls and IH-exposed mice, with three images per mouse. Autofluorescence with the TRITC channel was used to define alveolar areas. (<bold>C</bold>) Alveolar wall thickness was quantified in Imaris, using the measurement tool for autofluorescence to define the alveolar walls. A total of 20 alveolar wall thickness measurements were taken for each 60× magnification confocal image (n = 2 mice per treatment, six images per mouse).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig3-figsupp2-v3.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Diverse expression pathways were up- and downregulated in the presence of IH</title><p>We further explored the early cell type-specific response to IH in mouse lung by aggregating single-cell data into ‘pseudo-bulk’ data to compare biological replicates for each identified cell type (see Materials and methods for details). For each biological replicate, we summed the reads for each gene in the same cell type. Total read counts between replicates and the two conditions were normalized by size factors in DESeq2 to reduce the impact of cell number differences. Using DESeq2 (<xref ref-type="bibr" rid="bib68">Love et al., 2014</xref>), the number of up- or downregulated genes in different lung cell types in response to IH were not equal at the same statistical cutoff (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). For example, there were 607 and 550 genes up- and downregulated in endothelial cells, while there were 186 and 139 genes up- and downregulated in B cells at p&lt;0.05. We selected the top 200 up- and downregulated genes (ranking by the p-value) from each cell type in the pathway enrichment analysis to balance the input gene number difference. From the DAVID enrichment analysis, diverse biological processes were up- and downregulated in different cell types in response to IH (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A,B</xref>). For example, hypoxia-responsive and circadian pathways were enriched in those upregulated genes in response to IH in endothelial cells, myofibroblasts, and AT2 cells. Surprisingly, circadian pathways were highly enriched in multiple cell populations, not just epithelial cells, a population that is important for circadian rhythmicity in the lung (<xref ref-type="bibr" rid="bib34">Gibbs et al., 2009</xref>). The co-upregulation of genes in these two pathways suggest that the genome-wide co-regulation of hypoxia and the circadian pathway is tighter in lung endothelial, myofibroblast, and AT2 cells than other cell types.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Diverse expression pathways were up- and downregulated in the presence of intermittent hypoxia.</title><p>(<bold>A</bold>) Biological processes enriched in different cell types from lungs of mice exposed to IH vs controls. Enrichment analysis was performed in the DAVID database, using the top 200 up- and downregulated genes identified from each cell type. Redundant biological processes are merged into one category. Biological processes enriched in up- and downregulated genes are indicated in red and blue triangles, respectively. (<bold>B</bold>) Expression variation of well-established genes involved in circadian rhythm for endothelial, epithelial, and mesenchymal cells. (<bold>C</bold>) Expression variation of well-established genes involved in immune response for immune-associated cells. For (<bold>B</bold>) and (<bold>C</bold>), the fold change is indicated by the color, and the p-value for differential expression is indicated by the point size. The list of cell types include: endothelial cells (Endo), B cells (Bcells), natural killer cells (NK), T cells (Tcells), natural killer T cells (NK-T), macrophages (Mphage), basophils (Baso), monocytes (Mono), macrophages-dendritic CD163<sup>+</sup> cells (Mphage-DC), dendritic cells (DC), megakaryocytes (MegK), fibroblasts (FB), myofibroblasts (MyoFB), pericytes (Pcyte), alveolar epithelial type I cells (AT1), lymphatic endothelial cells (LymEndo), erythroblasts (Erythro), alveolar epithelial type II cells (AT2), and ciliated cells (Ciliated).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref> and <xref ref-type="fig" rid="fig4s2">2</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig4-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>p-value distribution of the top 200 up- and downregulated IH-responsive genes in 19 lung cell types.</title><p>Each red or blue point indicates one up- or downregulated gene. The black dashed line indicates a p-value of 0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig4-figsupp1-v3.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Enriched biological processes from differentially expressed genes from whole mouse lungs exposed to IH vs controls.</title><p>This figure shows enriched biological processes that were not listed in Figure 4. Those biological processes enriched in one specific cell type were shown in (<bold>B</bold>) while others were shown in (<bold>A</bold>). Enrichment analysis was performed in the DAVID database using the top 200 up- and downregulated genes identified from each cell type. Redundant biological processes are merged into one category. Biological processes enriched in up- and downregulated genes are indicated by red and blue triangles, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig4-figsupp2-v3.tif"/></fig></fig-group><p>Our data demonstrate that cell adhesion genes are upregulated in endothelial cells, myofibroblasts, fibroblasts, and pericytes after exposure to IH. These results suggest that lung endothelial and stromal cells may contribute to the increased circulating cell adhesion molecules in OSA patients. Interestingly, cell adhesion molecules that control leukocyte trafficking are increased in OSA patients (<xref ref-type="bibr" rid="bib78">Ohga et al., 1999</xref>) and reduced after continuous positive airway pressure (CPAP) treatment (<xref ref-type="bibr" rid="bib16">Chin et al., 2000</xref>; <xref ref-type="bibr" rid="bib81">Pak et al., 2015</xref>). Immune response-related and antigen processing and presentation were enriched among those downregulated genes in monocytes, macrophages-dendritic cells, NK cells, and erythroblasts. The decrease among immune related genes in these cell types is consistent with the bulk RNA-seq data. It is known that a hypoxic tumor microenvironment will induce immunosuppression (<xref ref-type="bibr" rid="bib97">Sitkovsky et al., 2008</xref>). Hypoxia may also cause immunosuppression in patients with OSA and contribute to the increased incidence of lung cancer in this population (<xref ref-type="bibr" rid="bib11">Campos-Rodriguez et al., 2013</xref>).</p><p>As expected from specific genes in each biological process, the response level of the same genes were different in multiple cell types (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>). For example, the circadian repressor gene, <italic>Nr1d1,</italic> was more responsive to IH in endothelial and AT2 cells than lymphatic endothelial cells and AT1 cells. We also noted cell-specific responses for the downregulated genes. For example, immune response genes (e.g. <italic>Iglc3</italic>, <italic>S100a8</italic>, and <italic>Oas3</italic>) decreased more in monocytes than macrophages in response to IH. These results suggest that a cell type-specific response to short exposures of IH exists at a single-gene level, findings that may be related to the progression of OSA-associated chronic pulmonary diseases. For example, bleomycin-induced fibrosis is induced in mice by an <italic>Nr1d1</italic> mutation in specific lung cells (<xref ref-type="bibr" rid="bib20">Cunningham et al., 2020</xref>).</p></sec><sec id="s2-5"><title>Pulmonary vascular endothelial subpopulations show distinctive responses to IH</title><p>Recent studies show distinct vascular endothelial cell subpopulations in mouse and human lung (<xref ref-type="bibr" rid="bib36">Gillich et al., 2020</xref>). Our vascular endothelial populations were annotated to endothelial artery, vein, capillary aerocytes (Cap-a), and general capillary (Cap-g) cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Interestingly, we found that endothelial cells demonstrated profound changes in gene expression profiles in response to IH. The endothelial capillary cells were more responsive to IH compared to endothelial artery and vein cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). For example, at BHQ &lt; 0.2, more than 100 genes were significantly upregulated in aerocytes and general capillary cells. However, only one gene in the arterial endothelial cells and 57 genes in the venular endothelial cells were significantly upregulated at the same cutoff. This trend persisted at other BHQ cutoffs (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Given the location of lung capillary cells around the alveoli and positioned at the air–blood barrier, these results indicate that the capillary cells may be among the first lung endothelial cell groups that respond early after initial exposure to IH. Among the capillary cells, general capillary cells are more responsive to hypoxia than aerocytes. More genes were significantly up and downregulated in general capillary cells than aerocytes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Hypoxia-responsive genes (e.g. <italic>Pdk1</italic>, <italic>Vegfc</italic>, <italic>Slc2a1</italic>, <italic>Pkm</italic>, and <italic>Flt1</italic>) showed higher levels of expression variation (fold change and significance) in general capillary cells than aerocytes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), demonstrating variation at the subpopulation level. Aerocytes are specialized for gas exchange, and general capillary cells function in capillary homeostasis and aerocyte production during repair (<xref ref-type="bibr" rid="bib36">Gillich et al., 2020</xref>). Our observed response from general capillary cells may be related to its role in capillary homeostasis. Alternatively, proximity and interaction with other cell types, such as fibroblasts or immune cells, may also help to explain these findings. For example, general capillary cells contact stromal cells while aerocytes lie in close proximity to AT1 cells (<xref ref-type="bibr" rid="bib36">Gillich et al., 2020</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Pulmonary vascular endothelial subpopulations show distinctive responses to intermittent hypoxia.</title><p>(<bold>A</bold>) UMAP projection of cells from four lung endothelial subpopulations. There are 22 cells outside the range of this figure. (<bold>B</bold>) The number of differentially expressed (BHQ &lt; 0.2) genes in each endothelial subpopulation from IH vs controls. (<bold>C</bold>) Expression variation of related genes in response to IH is shown for each endothelial subpopulation. Biological processes enriched in aerocytes (<bold>D</bold>) and general capillary cells (<bold>E</bold>) from IH vs control mice. Enrichment analysis was performed in the DAVID database, using up- and downregulated genes (BHQ &lt; 0.2). Redundant biological processes are merged into one category. Top five biological processes enriched in up and downregulated genes are indicated in red and blue bars, respectively. The list of endothelial subpopulations include endothelial artery (EndoArt), vein (EndoVein), general capillary (EndoCap-g) cells, and aerocytes (EndoCap-a).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref>–<xref ref-type="fig" rid="fig5s3">3</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig5-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Validation of endothelial subpopulation assignments with known markers.</title><p>The marker genes collected from the literature and assigned endothelial subpopulations are listed on the y-axis and x-axis, respectively. The average CPM (count per million reads) of three replicates from control (gray) and IH (orange)-exposed mice are indicated by the height of the bar. The error bars indicate standard deviation based on the three biological replicates. The average percentage of cells with detected expression of each marker gene among the endothelial subpopulations is indicated by the heatmap color. The four endothelial subpopulations include endothelial artery (EndoArt), vein (EndoVein), general capillary (EndoCap-g) cells, and capillary aerocytes (EndoCap-a).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig5-figsupp1-v3.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Number of differentially expressed IH-responsive genes in four lung endothelial subpopulations using BHQ cutoffs.</title><p>At series BHQ cutoffs, the number of up- and downregulated genes in lung endothelial subpopulations as a response to IH are shown with red and blue lines, respectively. The four endothelial subpopulations include endothelial artery (EndoArt), vein (EndoVein), general capillary (EndoCap-g) cells, and capillary aerocytes (EndoCap-a).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig5-figsupp2-v3.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Predicted key transcription factors (TFs) for the endothelial capillary subtypes.</title><p>The predicted transcriptional regulatory network (TRN) for general capillary cells (<bold>A</bold>) and aerocytes (<bold>B</bold>) by SINCERA. Top 25 predicted TFs, from control and IH-exposed mice, are selected, and the overlapped TFs are shown in the figure. Orange nodes represent TFs, gray nodes represent target genes, and edges represent the predicted regulatory interactions between TFs and target genes. The shared TFs between general capillary cells and aerocytes are indicated with circle nodes, and the remaining TFs are indicated with square nodes. The size is in concordance with the average ranking; the higher the ranking, the larger the size.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig5-figsupp3-v3.tif"/></fig></fig-group><p>We further compared the response of general capillary cells and aerocytes to IH at the pathway level. Glycolytic process was upregulated and cell migration was downregulated in both aerocytes and general capillary cells in response to IH (<xref ref-type="fig" rid="fig5">Figure 5D,E</xref>). Given the association between glycolysis, cytoskeletal remodeling, and cell migration in other cell types (<xref ref-type="bibr" rid="bib94">Shiraishi et al., 2015</xref>), the similar enrichment trends for these pathways is not surprising. Additionally, without vascular growth associated with chronic IH, glycolysis may be used to meet metabolic demand. Interestingly, changes in the glycolytic process were specific to endothelial cell types (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). On the other hand, aerocytes and general capillary cells demonstrated more differences in enrichment pathways (<xref ref-type="fig" rid="fig5">Figure 5D,E</xref>). For example, regulation of cell proliferation and regulation of angiogenesis were only enriched for those up- and downregulated genes in general capillary cells in response to IH. These pathways are tightly correlated with its specific role in capillary homeostasis as a capillary progenitor cell and in regulation of vasomotor tone (<xref ref-type="bibr" rid="bib36">Gillich et al., 2020</xref>). While phagocytosis, immune response, and regulation of cell shape were only enriched for those downregulated genes in aerocytes (<xref ref-type="fig" rid="fig5">Figure 5D,E</xref>), this may reflect aerocyte’s specific role in leukocyte trafficking and gas exchange, both highly influenced by exposure to IH.</p><p>We used SINCERA (<xref ref-type="bibr" rid="bib40">Guo et al., 2015</xref>) to predict key transcription factors (TFs) in the inferred transcriptional regulatory network in general capillary and aerocytes (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A,B</xref>; Materials and methods). Hypoxia-associated TFs (e.g. <italic>Epas1</italic>, <italic>Jun</italic>, and <italic>Ahr)</italic>, <italic>Foxf1</italic> (canonical endothelial cell marker), and <italic>Ybx1</italic> (glycolysis related) were among the top-ranked TFs in both aerocytes and general capillary cells. <italic>Tbx2</italic>, <italic>Tbx3</italic>, and <italic>Meox1</italic> were among the top-ranked TFs only in aerocytes, which are considered aerocyte-specific TFs (<xref ref-type="bibr" rid="bib36">Gillich et al., 2020</xref>). Interestingly, three immune response-related TFs (<italic>Hlx</italic>, <italic>Rarg</italic>, and <italic>Smarca2</italic>) were only top-ranked in aerocytes. Additionally,<italic>Tcf4</italic> and <italic>Sox17</italic> were among the top-ranked TFs only in general capillary cells, which are associated with endothelial cell regeneration or stem cell self-renewal (<xref ref-type="bibr" rid="bib111">van Es et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Liu et al., 2019</xref>). <italic>Elk3</italic> and <italic>Casz1</italic> were among the top-ranked TFs in general capillary cells and are related to angiogenesis (<xref ref-type="bibr" rid="bib44">Heo and Cho, 2014</xref>; <xref ref-type="bibr" rid="bib14">Charpentier et al., 2013</xref>). The pathway-level differences between aerocytes and general capillary cells may be driven by these predicted top-ranked TFs, which need further experimental validation.</p><p>Evaluation of the expression pathways at the single-cell resolution demonstrated significant changes in multiple cell types. With this information, we then wanted to identify potential candidates for therapeutic intervention in response to IH.</p></sec><sec id="s2-6"><title>Pulmonary disease-regulated genes provide clinical implications for OSA at the cell-specific level</title><p>OSA is associated with an array of pulmonary diseases, such as interstitial lung disease (ILD) (<xref ref-type="bibr" rid="bib53">Kim et al., 2017</xref>), idiopathic pulmonary fibrosis (IPF) (<xref ref-type="bibr" rid="bib61">Lancaster et al., 2009</xref>), and pulmonary hypertension (PH) (<xref ref-type="bibr" rid="bib90">Sajkov and McEvoy, 2009</xref>; <xref ref-type="bibr" rid="bib13">Chaouat et al., 1996</xref>). IH led to significantly more upregulated than downregulated pulmonary disease-associated genes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). IH-induced expression in myofibroblasts and fibroblasts demonstrated enrichment of genes associated with pulmonary fibrosis (PF). However, the disease genes were not equally expressed or upregulated in these cell types (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). For example, <italic>Ptgis</italic> is a PH-associated gene highly expressed in myofibroblasts and fibroblasts compared to other cell types (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). <italic>Ptgis</italic> is also a target gene for epoprostenol – a drug used for treating PH (<xref ref-type="bibr" rid="bib96">Sitbon and Vonk Noordegraaf, 2017</xref>). The IPF-associated gene, <italic>Thbs1</italic> (<xref ref-type="bibr" rid="bib48">Idell et al., 1989</xref>; <xref ref-type="bibr" rid="bib59">Kuhn and Mason, 1995</xref>; <xref ref-type="bibr" rid="bib120">Yehualaeshet et al., 2000</xref>), was highly expressed and more responsive to IH in myofibroblasts compared to other cell types. <italic>THBS1</italic> is upregulated in lung stromal cells of patients with chronic interstitial lung diseases (e.g. IPF) compared to healthy controls (Gene Explorer under Banovich/Kropski in <ext-link ext-link-type="uri" xlink:href="http://www.ipfcellatlas.com/">http://www.ipfcellatlas.com/</ext-link>; <xref ref-type="bibr" rid="bib42">Habermann et al., 2020</xref>). <italic>Msr1</italic> (<xref ref-type="bibr" rid="bib95">Silverman et al., 2002</xref>; <xref ref-type="bibr" rid="bib45">Hersh et al., 2006</xref>) is a chronic obstructive pulmonary disease (COPD)-associated gene, which was highly expressed in macrophage-DCs, basophils, and monocytes, consistent with scRNA-seq data from patients with IPF (Gene Explorer under Banovich/Kropski in <ext-link ext-link-type="uri" xlink:href="http://www.ipfcellatlas.com/">http://www.ipfcellatlas.com/</ext-link>; <xref ref-type="bibr" rid="bib42">Habermann et al., 2020</xref>). These data highlight the similarity of the IH-associated signatures with cell type-specific responses in an array of pulmonary diseases.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Pulmonary disease-regulated genes provide clinical implications for OSA at the cell-specific level.</title><p>(<bold>A</bold>) Pulmonary disease-associated genes are enriched in upregulated genes in different cell types from whole lungs of mice exposed to IH vs controls. Enrichment analysis was performed in the DisGenet human database, using the top 200 upregulated genes identified from each cell type. The enrichment ratio is indicated by color. The point size indicates the enrichment BHQ from a Fisher’s exact test. The pulmonary diseases include asthma, allergic asthma, chronic obstructive airway disease (COPD), interstitial lung fibrosis (ILF), pulmonary fibrosis (PF), idiopathic pulmonary fibrosis (IPF), pulmonary hypertension (PH), idiopathic pulmonary hypertension (IPH), and idiopathic pulmonary arterial hypertension (IPAH). (<bold>B</bold>) The disease-associated genes vary in expression level and percentage of cells that express those genes. The fold change is indicated by the color, and the percentage of cells that express those genes is indicated by the height of the bar. Control and experimental groups are indicated by gray and orange box borders, respectively. (<bold>C</bold>) Dozens of pulmonary drug targets show differential expression in multiple cell types in lungs from mice exposed to IH. Drug classes used to treat different pulmonary diseases are indicated by text color. Drug effect is indicated by the line type. Fold change is indicated by the point color, and the p-value of differential expression is indicated by the point size. (<bold>D</bold>) The hive plot shows ligand–receptor interaction changes between pairs of cell types in response to IH. Nodes indicate cell-expressed ligands (horizontal axis) or receptors (vertical axis). Size of nodes are in proportion to the number of interactions changed for the cell type. Width of lines show numbers of interactions gained (right) or lost (left) between the pairs of cell types. The list of cell types include endothelial cells (Endo), B cells (Bcells), natural killer cells (NK), T cells (Tcells), natural killer T cells (NK-T), macrophages (Mphage), basophils (Baso), monocytes (Mono), macrophages-dendritic CD163<sup>+</sup> cells (Mphage-DC), dendritic cells (DC), megakaryocytes (MegK), fibroblasts (FB), myofibroblasts (MyoFB), pericytes (Pcyte), alveolar epithelial type I cells (AT1), lymphatic endothelial cells (LymEndo), erythroblasts (Erythro), alveolar epithelial type II cells (AT2), and ciliated cells (Ciliated).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref>–<xref ref-type="fig" rid="fig6s5">5</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63003-fig6-data1-v3.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Pulmonary disease-associated genes are enriched in downregulated genes in different cell types in the lung from mice exposed to IH.</title><p>Enrichment analysis was performed in the DisGenet database, using the top 200 downregulated genes identified from each cell type. The average fold change of downregulated genes in each cell type for the same disease is indicated by color scale. The point size indicates the enrichment BHQ value from the Fisher’s exact test. The point color indicates the enrichment ratio. The pulmonary diseases include asthma, allergic asthma, chronic obstructive airway disease (COPD), and pulmonary hypertension (PH).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Pulmonary drug targets with cell type-specific expression profiles in mouse lung.</title><p>The average CPM (count per million reads) of three controls (gray) and IH-exposed (orange) replicates are indicated by the height of the bar. The error bar indicates standard deviation from the three biological replicates. The average percentage of cells with detected expression of each marker gene among specific cell types is indicated by the color scale. The list of cell types include endothelial cells (Endo), B cells (Bcells), natural killer cells (NK), T cells (Tcells), natural killer T cells (NK-T), macrophages (Mphage), basophils (Baso), monocytes (Mono), macrophages-dendritic CD163<sup>+</sup> cells (Mphage-DC), dendritic cells (DC), megakaryocytes (MegK), fibroblasts (FB), myofibroblasts (MyoFB), pericytes (Pcyte), alveolar epithelial type I cells (AT1), lymphatic endothelial cells (LymEndo), erythroblasts (Erythro), alveolar epithelial type II cells (AT2), and ciliated cells (Ciliated).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-figsupp2-v3.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Ligand–receptor interaction analysis reveals a major role for myofibroblasts in activating the FGF signaling pathway as a response to IH.</title><p>Heatmap shows ligand–receptor pair interaction changes in different cell pairs. Gene symbols of human homolog genes were used in this figure. Orange indicates a new interaction found in response to IH but not in control samples (gain of interaction), and blue indicates an interaction found in controls, but not in response to IH (loss of interaction). Myofibroblasts show a gain of interaction between <italic>Fgf2</italic>(<italic>FGF2</italic>), <italic>Fgf7</italic>(<italic>FGF7</italic>), and <italic>Ncam1</italic>(<italic>NCAM1</italic>) to the FGF receptor in multiple cell types, indicating its role in activating the FGF signaling pathway in response to IH.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-figsupp3-v3.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Enriched REACTOME gene sets for lung myofibroblast cells in mice exposed to IH vs controls.</title><p>The GSEA was run on expressed genes in myofibroblast ranked by the fold change between IH and control samples. The significantly enriched gene sets were selected by padj&lt;0.15 and absolute NES value above 1.7.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-figsupp4-v3.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Prediction of key transcription factors (TFs) for the myofibroblast.</title><p>Top 25 SINCERA predicted TFs from myofibroblast cells in the IH group are selected. The selected TFs are compared to all the predicted TFs from myofibroblast cells in the control group. Orange nodes represent TFs shared between myofibroblast cells in control and IH groups, and red nodes represent specific TFs in myofibroblast cells in the IH group. Gray nodes represent target genes, while edges represent the predicted regulatory interactions between TFs and target genes. The size is in concordance with the average ranking; the higher the ranking, the larger the size.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-fig6-figsupp5-v3.tif"/></fig></fig-group><p>The top 200 up- or downregulated genes in each cell type exposed to IH were linked with drug target genes extracted from DrugBank (<xref ref-type="bibr" rid="bib115">Wishart et al., 2008</xref>). We obtained 42 drugs used as activators or inhibitors of 23 target genes to treat pulmonary hypertension, pulmonary fibrosis, COPD, and asthma (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Interestingly, nearly one third of these drug target genes were more responsive to IH in endothelial cells compared to other cell types (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). We further evaluated changes in the interactions of these drug-targeted disease genes in each cell type using CellPhoneDB (<xref ref-type="bibr" rid="bib112">Vento-Tormo et al., 2018</xref>). There were 32 ligand–receptor interactions found in the database using these drug-targeted disease genes. Overall, myofibroblasts were involved in 98 of 176 gains of interaction (BHQ = 4.28e-50), demonstrating the significance of this cell type in early IH-associated responses (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). Here, we showed the importance of myofibroblasts in activating the fibroblast growth factor (FGF) signaling pathway (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). We then performed further analysis on myofibroblasts. The GSEA showed upregulation of multiple extracellular matrices (ECM)-associated pathways (e.g. ECM proteoglycans, non-integrin membrane ECM interactions, and collagen chain trimerization) in myofibroblasts (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>) after exposure to IH. FGF signaling pathway has a tight interaction with ECM (<xref ref-type="bibr" rid="bib102">Taipale and Keski-Oja, 1997</xref>; <xref ref-type="bibr" rid="bib79">Ornitz and Itoh, 2015</xref>), which may be associated with activation of the FGF signaling pathway in myofibroblasts in response to IH. In the inferred transcriptional regulatory network, the majority of the 25 top-ranked TFs were shared between the control and IH groups (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>). Interestingly, only <italic>Dbp</italic> and <italic>Hlf</italic> were top-ranked TFs in mice exposed to IH (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5</xref>). These results suggest that IH-induced circadian dysregulation may drive the transcriptional changes in myofibroblasts.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>OSA results from intermittent episodes of airway collapse and hypoxemia and is associated with dementia (<xref ref-type="bibr" rid="bib80">Osorio et al., 2015</xref>), diabetes (<xref ref-type="bibr" rid="bib87">Punjabi and Beamer, 2009</xref>), hypertension (<xref ref-type="bibr" rid="bib72">Marin et al., 2012</xref>), heart failure (<xref ref-type="bibr" rid="bib37">Gottlieb et al., 2010</xref>), and stroke (<xref ref-type="bibr" rid="bib110">Valham et al., 2008</xref>). How cellular responses to IH and hypoxemia initiate and cause disease progression in multiple organs remains unknown. Using IH as a mouse model of OSA, we show profound, cell type-specific changes in genome-wide RNA expression in the lung. RNA profiles from lungs of mice exposed to IH shared similarity with gene expression changes in human lung from patients with pulmonary disease, including PH, COPD, and asthma. OSA is associated with injury to alveolar epithelial cells and extracellular matrix remodeling, key features of ILD (<xref ref-type="bibr" rid="bib53">Kim et al., 2017</xref>). Although it is known that pulmonary diseases share general mechanisms, such as systemic inflammation and oxidative stress (<xref ref-type="bibr" rid="bib74">McNicholas, 2009</xref>), there is an incomplete understanding of the early-stage changes in the lung from OSA.</p><p>In the present study, macrophages, dendritic cells, and NK cells were the only populations to demonstrate altered oxidation–reduction in the early stages of IH exposure. It was previously demonstrated that chronic IH in mice caused the release of free oxygen radicals in the lung (<xref ref-type="bibr" rid="bib109">Tuleta et al., 2016</xref>), effects that could be blunted with antioxidative agents (<xref ref-type="bibr" rid="bib109">Tuleta et al., 2016</xref>). PH from chronic IH was associated with enhanced NADPH oxidase expression, and knockout mice lacking one of these subunits demonstrated attenuated effects of chronic IH (<xref ref-type="bibr" rid="bib77">Nisbet et al., 2009</xref>). Which cells mediate these effects in the lung? This type of knowledge can help direct therapeutics to the most relevant cells and molecular pathways.</p><p>Our data provide insight into the early cellular responses that drive disease progression in OSA. By identifying the roles of individual cells in disease, we have the opportunity to test targeted therapeutics, focusing specifically on the most pathologically relevant cells and molecular pathways. Using these data, we further explored the possibility of selecting novel drug target candidates in other cell types. Studies using scRNA-seq are already being used to identify novel cell populations in disease. For example, <xref ref-type="bibr" rid="bib118">Xu et al., 2016</xref> identified a loss of normal epithelial cells in the development of IPF. In another study using single-cell profiling of bronchial epithelial cells, the major source of cystic fibrosis transmembrane conductance regulator (CFTR) activity, the pulmonary ionocyte, was revealed (<xref ref-type="bibr" rid="bib86">Plasschaert et al., 2018</xref>). As <italic>CFTR</italic> is the gene mutated in cystic fibrosis, cell-specific therapies for this disease can now be evaluated.</p><p>In our mice exposed to IH, prostacyclin synthase (<italic>Ptgis</italic>) expression was dramatically upregulated in myofibroblasts and fibroblasts. As a potent vasodilator and inhibitor of platelet aggregation, therapies targeting this pathway are already used for patients with pulmonary arterial hypertension (<xref ref-type="bibr" rid="bib29">Farber and Gin-Sing, 2016</xref>). As another example, fibroblast growth factor receptor 2 (<italic>FGFR2</italic>) is highly expressed in AT2 cells. FGFR2 promotes alveolar regeneration in response to lung injury (<xref ref-type="bibr" rid="bib83">Perl and Gale, 2009</xref>) and is upregulated in patients with IPF (<xref ref-type="bibr" rid="bib64">Li et al., 2018</xref>). Previous studies suggest that OSA can induce injury to the lung (<xref ref-type="bibr" rid="bib2">Aihara et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Lederer et al., 2009</xref>), and OSA is prevalent in patients with IPF (<xref ref-type="bibr" rid="bib61">Lancaster et al., 2009</xref>). If OSA does, in fact, lead to fibrotic changes in the lung, targeting FGF pathways in alveolar epithelial cells could prevent disease progression from IH.</p><p>Although there is limited data on the role of the circadian clock in OSA (<xref ref-type="bibr" rid="bib113">von Allmen et al., 2018</xref>; <xref ref-type="bibr" rid="bib119">Yang et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Gabryelska et al., 2020</xref>), it may play a significant role in this disease (<xref ref-type="bibr" rid="bib28">Entzian et al., 1996</xref>; <xref ref-type="bibr" rid="bib98">Smith et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Butler et al., 2015</xref>). We found dysregulation of circadian gene expression in multiple cell types. The circadian clock is a transcriptional/translational feedback loop that coordinates ~24 hr timing of physiological functions. BMAL1, the key clock TF (<xref ref-type="bibr" rid="bib46">Hogenesch et al., 1998</xref>), interacts with CLOCK (<xref ref-type="bibr" rid="bib54">King et al., 1997</xref>) and its partner NPAS2 (<xref ref-type="bibr" rid="bib125">Zhou et al., 1997</xref>) to activate hundreds of target genes. All three are members of the basic helix-loop-helix (bHLH)-PER-ARNT-SIM (PAS) TF family. The HIFs (1–3) are members of the same TF family and are stabilized under low-oxygen conditions. Alterations in expression of clock genes are reported in peripheral blood cells from patients with OSA (<xref ref-type="bibr" rid="bib119">Yang et al., 2019</xref>). These changes in expression in blood cells are not affected by CPAP treatment (<xref ref-type="bibr" rid="bib75">Moreira et al., 2017</xref>), suggesting that they persist despite treatment. It is known that the circadian clock in alveolar epithelial cells impacts pulmonary physiology, and its disruption can contribute to disease in animal models (<xref ref-type="bibr" rid="bib124">Zhang et al., 2019</xref>). More importantly, IH leads to intertissue circadian misalignment (including in the lung) in mice (<xref ref-type="bibr" rid="bib70">Manella et al., 2020</xref>). The hypoxic episodes that define OSA are clearly diurnal, but we do not understand if clock disruption is a cause or consequence of disease. Our findings suggest that circadian clock dysfunction may be an important early-stage consequence of hypoxia-driven disease and may contribute to downstream processes.</p><p>Lung samples from IH-exposed mice did <italic>not</italic> show comprehensive histopathologic changes. This contrasts with findings from some prior murine models of IH. For example, IH induced epithelial cell proliferation in lungs (<xref ref-type="bibr" rid="bib88">Reinke et al., 2011a</xref>). These models also produced other phenotypic changes, such as increased lung volumes (<xref ref-type="bibr" rid="bib89">Reinke et al., 2011b</xref>). In a bleomycin-induced lung injury model, fibrosis in mouse lung is worsened by IH (<xref ref-type="bibr" rid="bib35">Gille et al., 2018</xref>). In our model, short-term exposure to IH did not result in changes to the parenchyma or vessels. This is likely attributed to the difference in the length of time of IH exposure. We exposed our mice to IH for a shorter period of time to specifically evaluate the changes in gene expression prior to comprehensive lung remodeling with the hope of uncovering early pathways that lead to disease. Based on the shorter time of exposure, we are likely seeing molecular changes from IH with minimal gross architectural changes to the lung. Future longitudinal studies should address how gene expression profiles change over time and which cell types drive disease progression from early to late IH exposure. Early insults from hypoxia may also drive organ-specific damage in other systems. Although models of IH replicate desaturation and recovery of fractional inhaled oxygen, there is variability in the number of hypoxic events, length of desaturation events, and length of overall exposure. This variability could affect expression profiles and histopathologic findings.</p><p>Several different animal models have been designed for the study of OSA and those associated pathophysiologic sequelae, each with its own advantages and disadvantages. For example, early studies using animal models made use of implanted balloons (<xref ref-type="bibr" rid="bib17">Crossland et al., 2013</xref>). The most widely used model, implemented here, uses cyclic episodes of IH with recovery to room air during inactive phases (<xref ref-type="bibr" rid="bib107">Trzepizur et al., 2018</xref>). Both models can produce vascular and metabolic disturbances associated with OSA, such as sympathetic dysregulation (<xref ref-type="bibr" rid="bib12">Chalacheva et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Ferreira et al., 2020</xref>), changes in blood pressure (<xref ref-type="bibr" rid="bib17">Crossland et al., 2013</xref>; <xref ref-type="bibr" rid="bib93">Schulz et al., 2014</xref>), and metabolic dysregulation (<xref ref-type="bibr" rid="bib63">Li et al., 2005</xref>; <xref ref-type="bibr" rid="bib50">Jun et al., 2014</xref>). Chronic exposure to IH has also been shown to induce lung growth in adult mice (<xref ref-type="bibr" rid="bib89">Reinke et al., 2011b</xref>). Models using IH allow for the study of oxygen desaturations without the need for surgical implantation or scarring in the airway.</p><p>Delineating the upstream processes dysregulated in OSA could help us identify potential candidates for therapeutic intervention. Given the socioeconomic burden to our healthcare system for diagnosing and treating OSA, new diagnostic and therapeutic strategies will be vital for the coming years.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>Mus musculus</italic>, <break/>C57BL/6J)</td><td valign="top">Wild-type C57BL/6 (WT)</td><td valign="top">Jackson Laboratories</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:026133">IMSR_JAX:026133</ext-link></td><td valign="top">See Materials and methods</td></tr><tr><td>Antibody</td><td>Anti-FOXF1 <break/>(Goat Polyclonal)</td><td>R and D Systems</td><td>Cat# AF4798, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2105588">AB_2105588</ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-Lyve1 <break/>(Rabbit Polyclonal)</td><td>Abcam</td><td>Cat# AB14917, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_301509"><underline>AB_301509</underline></ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-actin, smooth <break/>muscle (Mouse <break/>Monoclonal IgG2A)</td><td>Sigma–Aldrich</td><td>Cat# A5228, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_262054">AB_262054</ext-link></td><td>IF (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-Ki-67 <break/>(Monoclonal <break/>Mouse IgG1)</td><td>BD Biosciences</td><td>Cat# 556003, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_396287">AB_396287</ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-SFTPC <break/>(Rabbit Polyclonal)</td><td>Seven Hills Bioreagents</td><td>Cat# WRAB-9337, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2335890">AB_2335890</ext-link></td><td>IF (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-Periostin <break/>(Rabbit Polyclonal)</td><td>Abcam</td><td>Cat# ab215199</td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-Endomucin <break/>(Goat Polyclonal)</td><td>R and D Systems</td><td>Cat# AF4666, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2100035">AB_2100035</ext-link></td><td>IF (1:200)</td></tr><tr><td>Antibody</td><td>Anti-SOX9 <break/>(Rabbit Polyclonal)</td><td>Millipore Sigma</td><td>Cat# AB5535, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2239761">AB_2239761</ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>Anti-Hop (E1), <break/>(Monoclonal <break/>Mouse IgG1)</td><td>Santa Cruz Biotechnology</td><td>Cat# SC_398703, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687966">AB_2687966</ext-link></td><td>IF (1:100)</td></tr><tr><td>Commercial <break/>assay or kit</td><td>Collagenase, elastase, <break/>dispase digestion buffer</td><td>Sigma-Aldrich; Worthington Biochemical</td><td/><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>Bacillus <break/>licheniformis mix</td><td>Sigma-Aldrich</td><td/><td/></tr><tr><td>Software, algorithm</td><td>Imaris (Bitplane)</td><td><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/">https://imaris.oxinst.com/</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link></td><td>Version 9.6</td></tr><tr><td>Software, algorithm</td><td>Nikon <break/>NIS-Elements software</td><td><ext-link ext-link-type="uri" xlink:href="https://www.microscope.healthcare.nikon.com/en_EU/products/software/nis-elements">https://www.microscope.healthcare.nikon.com/en_EU/products/software/nis-elements</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014329">SCR_014329</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>STAR</td><td><xref ref-type="bibr" rid="bib22">Dobin et al., 2013</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015899">SCR_015899</ext-link></td><td>Version 2.5</td></tr><tr><td>Software, algorithm</td><td>HTSeq</td><td><xref ref-type="bibr" rid="bib6">Anders et al., 2015</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005514">SCR_005514</ext-link></td><td>Version 0.6.0</td></tr><tr><td>Software, algorithm</td><td>Cell Ranger</td><td><ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/downloads/latest">https://support.10xgenomics.com/single-cell-gene-expression/software/downloads/latest</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017344">SCR_017344</ext-link></td><td>Version 2.1.1</td></tr><tr><td>Software, algorithm</td><td>AltAnalyze</td><td><ext-link ext-link-type="uri" xlink:href="http://www.altanalyze.org/">http://www.altanalyze.org/</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002951">SCR_002951</ext-link></td><td>Version 2.1.2</td></tr><tr><td>Software, algorithm</td><td>DESeq2</td><td><xref ref-type="bibr" rid="bib68">Love et al., 2014</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015687">SCR_015687</ext-link></td><td>Version 1.24.0</td></tr><tr><td>Software, algorithm</td><td>cellHarmony</td><td><xref ref-type="bibr" rid="bib21">DePasquale et al., 2019</xref></td><td/><td/></tr><tr><td>Software, algorithm</td><td>drugBankR</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/yduan004/drugbankR">https://github.com/yduan004/drugbankR</ext-link>; <xref ref-type="bibr" rid="bib24">Duan, 2019</xref></td><td/><td/></tr><tr><td>Software, algorithm</td><td>GOSemSim</td><td><xref ref-type="bibr" rid="bib121">Yu et al., 2010</xref></td><td/><td>Version 2.10.0</td></tr><tr><td>Software, algorithm</td><td>SINCERA</td><td><xref ref-type="bibr" rid="bib40">Guo et al., 2015</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016563">SCR_016563</ext-link></td><td>Version 0.99.0</td></tr><tr><td>Software, algorithm</td><td>CellPhoneDB</td><td><xref ref-type="bibr" rid="bib112">Vento-Tormo et al., 2018</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017054">SCR_017054</ext-link></td><td/></tr><tr><td>Other</td><td>DisGeNET</td><td><ext-link ext-link-type="uri" xlink:href="http://www.disgenet.org">http://www.disgenet.org</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006178">SCR_006178</ext-link></td><td>Version 6.0</td></tr><tr><td>Other</td><td>DrugBank</td><td><ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca/">http://www.drugbank.ca/</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002700">SCR_002700</ext-link></td><td>Version 5.1.4</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>Use of animals and all procedures were approved by the Institutional Animal Care and Use Committee at Cincinnati Children’s Hospital Medical Center and complied with the National Institutes of Health guidelines. Male C57BL/6J wild-type mice (RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:026133">IMSR_JAX:026133</ext-link>) aged 6 weeks were purchased from The Jackson Laboratory (Bar Harbor, ME) and entrained to a 12 hr:12 hr light:dark cycle for 2 weeks prior to exposure.</p></sec><sec id="s4-2"><title>Experimental design</title><p>All studies were conducted in 8–10 weeks old male mice. Mice were housed in light boxes and entrained to a 12:12 light:dark cycle for 2 weeks prior to initiation of IH. Mice were randomly assigned to IH or room air exposures. For the experimental group, mice were maintained in a commercially designed gas control delivery system (Model A84XOV, BioSpherix, Parish, NY) during the inactive (light) phase from (ZT 0–12). Mice were provided with food and water ad libitum. For each episode of IH, the fractional inhaled oxygen (O<sub>2</sub>) was reduced from 20.9% to 6% over a 50 s exposure period, followed by an immediate 50 s recovery period to 20.9%. The fractional oxygen was maintained at 20.9% for approximately 15 s before the cycle was repeated, allowing for ~30 hypoxic events per hour. Ambient temperature in the hypoxia chamber was maintained between 22 and 24°C to match room air. Mice in the experimental group were maintained at room air during the active phase, ZT 13–24. Mice in the control group were maintained at room air throughout the circadian cycle, ZT 0–24. Experimental and control mice were exposed to IH vs room air for 9 days, followed by sacrifice at ZT 3 on day 10 of exposure. This was immediately followed by organ harvest and preparation for bulk RNA-seq, scRNA-seq, or histopathology.</p><p>Animal models of IH are performed by exposing mice to cycling levels of room air (fraction of inspired oxygen [FiO<sub>2</sub>] – 21%) to different trough/nadir values (most commonly from 5 to 15%), producing dose–response effects (<xref ref-type="bibr" rid="bib76">Nagai et al., 2014</xref>; <xref ref-type="bibr" rid="bib66">Lim et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Gallego-Martin et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Farré et al., 2018</xref>). These fluctuations in FiO<sub>2</sub> translate to measured oxygen saturation (SaO<sub>2</sub>) nadir values of approximately 50–70% in mice (<xref ref-type="bibr" rid="bib49">Jun et al., 2010</xref>; <xref ref-type="bibr" rid="bib65">Lim et al., 2015</xref>; <xref ref-type="bibr" rid="bib89">Reinke et al., 2011b</xref>). These cycling SaO<sub>2</sub> nadirs in mice closely correspond to partial pressure of oxygen (PaO<sub>2</sub>) values seen in humans with OSA (<xref ref-type="bibr" rid="bib30">Farré et al., 2018</xref>). PaO<sub>2</sub> levels in humans are lower than for mice for any given SaO<sub>2</sub> value (<xref ref-type="bibr" rid="bib30">Farré et al., 2018</xref>). Hence, SaO<sub>2</sub> nadir values that commonly occur in patients with OSA (70–90%) correspond to SaO<sub>2</sub> nadir values (40–70%) in mice exposed to our cycling FiO<sub>2</sub> trough levels. Based on the diagnostic criteria for severe OSA in humans (<xref ref-type="bibr" rid="bib51">Kapur et al., 2017</xref>), our protocol for 30 hypoxic events an hour with cycling FiO<sub>2</sub> troughs of 6% in mice represent clinically severe OSA in humans.</p></sec><sec id="s4-3"><title>RNA isolation</title><p>In total, six experimental and six control mice were used for bulk RNA-seq. For bulk RNA-seq, the lung was quickly harvested and snap-frozen in liquid nitrogen. Organs were later homogenized in TRIzol reagent (Invitrogen) and processed using a bead mill homogenizer (Qiagen Tissuelyser). RNA was then isolated from lung homogenates by phase separation using chloroform and phase separation columns. The aqueous phase was then applied to an RNeasy column following the manufacturer’s protocol (Qiagen) to extract and purify the RNA.</p></sec><sec id="s4-4"><title>Bulk RNA sequencing and analysis</title><p>RNA from the lungs of control and experimental mice were sent for bulk sequencing separately. Approximately 0.4 µg of total RNA was used for library preparation. mRNA enrichment and library preparation were performed using the Polyadenylated (PolyA+) mRNA Magnetic Isolation Module (New England Biolabs) and NEBNext Ultra II RNA Library Prep Kit for Illumina (New England Biolabs), following the manufacturer’s protocol. All 12 samples were then pooled together and sequenced in one lane using Illumina Novaseq 6000 platform with paired-end 150 bp (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). The raw fastq files from RNA-seq were mapped to GRCm38 mouse genome reference using STAR (version 2.5) with default parameters. More than 90% (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>) of sequenced paired-end reads (above 50M reads for each library) were mapped to the mouse genome by STAR (<xref ref-type="bibr" rid="bib22">Dobin et al., 2013</xref>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015899">SCR_015899</ext-link>). HTSeq (<xref ref-type="bibr" rid="bib6">Anders et al., 2015</xref>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005514">SCR_005514</ext-link>) (version 0.6.0) was used to quantify gene expression, with Ensembl GRCm38.96 as a reference. DESeq2 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015687">SCR_015687</ext-link>; version 1.24.0) was used to perform the differential expression analysis on the HTSeq quantified count per gene. The top 200 up- and downregulated genes (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>), ranked by p-value from low to high with fold change above 1.5 (or log2[fold change] &gt; 0.58), were used for biological process enrichment analysis in the DAVID database. Biological process terms with at least five differentially expressed genes and BHQ &lt; 0.15 were selected. For aggregating redundant biological processes, GOSemSim (<xref ref-type="bibr" rid="bib121">Yu et al., 2010</xref>) (version 2.10.0) was used to calculate the semantic similarity (‘Jiang’ method from GOSemSim) between significant biological processes. Redundant biological processes were manually merged into biological process categories (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>).</p></sec><sec id="s4-5"><title>Dissociation protocol for single-cell sequencing</title><p>For scRNA-seq, a total of three biological replicates (three IH and three controls in the first experiment and two of each in the other replicates). On the last day of exposure, the mice were sacrificed, lung harvested, and tissue immediately placed in ice-cold phosphate-buffered saline (PBS). Dissociation of the pooled whole mouse lung for each group (IH vs control) was performed as previously described (<xref ref-type="bibr" rid="bib41">Guo et al., 2019</xref>). Briefly, minced lung was placed in collagenase/elastase/dispase digestion buffer (Sigma–Aldrich, St. Louis, MO; Worthington Biochemical, Lakewood, NJ). After mixing on ice for approximately 3 min, the lung was minced again. After resting the suspension, the supernatant was passed through a 30 µM filter. A <italic>Bacillus licheniformis</italic> mix (Sigma–Aldrich) was added to the cell suspension, mixed on ice for approximately 10 min, and passed through a 30 µM filter. The suspension was spun at 500 g for 5 min at 4°C. The pellet was rinsed with a red blood cell lysis buffer. This was again passed through a 30 µM filter and then spun at 500 g for 5 min at 4°C. The cell suspension was resuspended in PBS/bovine serum albumin and manually counted with a hemocytometer. The volume was adjusted to obtain a final concentration of approximately 1000 cells/µl to be loaded to the 10× Chromium platform.</p></sec><sec id="s4-6"><title>scRNA-seq library construction and sequencing</title><p>The single-cell suspension was applied to the 10× Genomics Chromium platform (San Francisco, CA) to capture and barcode cells, as described in the manufacturer’s protocol. Libraries were constructed using the Single Cell 3′ Reagent Kit (v2 Chemistry). The completed libraries were then sequenced using HiSeq 2500 (Illumina, San Diego, CA) running in Rapid Mode. Each sample was loaded onto two lanes of a Rapid v2 flow cell.</p><sec id="s4-6-1"><title>scRNA-seq data processing</title><p>Raw data from 10× Genomics were demultiplexed and converted to a fastq file using cellRanger (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017344">SCR_017344</ext-link>; v2.1.1) mkfastq. Reads from the same library sequenced in different flow cells (technical replicates) were combined and aligned to the mm10 genome reference using cellRanger count. Summary data for statistical mapping profiles are presented in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2a</xref>. The gene expression profiles for cells from the three biological replicates of the IH group were combined with cellRanger aggr and were run an unsupervised analysis using the software Iterative Clustering and Guide-gene Selection (ICGS) versions 2 (AltAnalyze version 2.1.2) to generate reference clusters using the program defaults with Euclidean clustering (<xref ref-type="bibr" rid="bib21">DePasquale et al., 2019</xref>). ICGS2 grouped 12,324 cells into 25 reference clusters based on the expression profiles of 1480 selected marker genes (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2b</xref>). All cells from control and IH groups were then aligned to these 25 reference clusters using cellHarmony (<xref ref-type="bibr" rid="bib21">DePasquale et al., 2019</xref>). Uniform Manifold Approximation and Projection (UMAP) calculation was run using integrated function in AltAnalyze (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002951">SCR_002951</ext-link>) -v2.1.2 with default parameters. For annotating the 25 reference clusters into known lung cell types, we prepared a comprehensive marker gene list for known lung cell types. The sources of this marker gene list included information from the Mouse Cell Atlas, ToppGene, and Lung Gene Expression Analysis (LGEA) (<xref ref-type="bibr" rid="bib101">Tabula Muris Consortium et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Chen et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">Du et al., 2017</xref>). Additionally, we manually collected cell marker genes from published scRNA-seq studies performed in mouse or human lung (<xref ref-type="bibr" rid="bib126">Zilionis et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Guo et al., 2019</xref>). One-tailed Fisher’s exact test was used to perform enrichment analysis between marker genes for each cluster and the curated reference markers of known lung cell types. Each cluster was manually assigned to a specific cell type based on the known cell type with the lowest BH (<xref ref-type="bibr" rid="bib8">Benjamini and Hochberg, 1995</xref>) adjusted p-value (GO-Elite software) (<xref ref-type="bibr" rid="bib122">Zambon et al., 2012</xref>). Those clusters corresponding to the same annotated cell type were manually joined as one cell type for downstream analyses (e.g. endothelial corresponding to four clusters). This process reduced the 25 reference clusters into 19 cell types (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2c</xref>). For testing the cell-type composition difference of mouse lung between experimental and control groups, a centered log ratio transformation was performed on the percentage of each cell type before applying the t-test (two tailed). The statistical p-value from the t-test was adjusted with the BH method.</p></sec></sec><sec id="s4-7"><title>Pseudo-bulk RNA-seq differential expression analysis</title><p>To identify differentially expressed genes in each lung cell type between the control and IH groups with multiple biologic replicates, all cells assigned to the same cell type were aggregated into a ‘pseudo-bulk’ data library by library. For each library, the sum of the reads per gene from cells assigned to the same cell type were used to represent the cell-type-specific gene expression profiles. Percentage of cells expressed per gene were calculated as a fraction of cells with ≥1 read(s) for the gene in each cell type. Count per one million UMI (CPM) for each cell type was calculated as the (sum of reads per gene/sum of reads) * 1,000,000 for each library. Differential expression analysis was performed with DESeq2 for each cell type, using the sum of reads per gene as input, with three replicates in each of the control and IH groups. Ranked by p-value from low to high, the top 200 up- and downregulated genes (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2d</xref>) with fold change above 1.2 (or log2[fold change] &gt; 0.26) were used for biological process enrichment analysis in the DAVID database. Selecting and aggregating biological processes (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2e</xref>) were performed as described in the Materials and methods section labeled, ‘Bulk RNA sequencing and analysis’. We further extracted those genes enriched in circadian rhythm and immune response and selected well-established genes in each biological process to demonstrate their expression variation under IH exposure in each cell type based on literature searches.</p></sec><sec id="s4-8"><title>Endothelial subpopulation analysis</title><p>To improve the accuracy for classifying endothelial cells, we reran the AltAnalyze-ICGS2 clustering algorithm using only the 5579 cells annotated to pulmonary vascular endothelial cells from IH-exposure groups, followed by a realignment of all vascular endothelial cells from both control and IH groups to these clusters using cellHarmony. AltAnalyze-ICGS2 produced six clusters with 314 marker genes (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3a</xref>). We matched the ICGS2-selected marker genes with vascular endothelial subpopulation marker genes presented in a study from <xref ref-type="bibr" rid="bib106">Travaglini et al., 2019</xref>. This annotated the clusters into four subpopulations of endothelial artery, vein, capillary aerocytes, and general capillary cells (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3b</xref>). We further aggregated all cells of the same vascular endothelial subpopulations into ‘pseudo-bulk’ data library by library. DESeq2 was used to detect differentially expressed genes for each subpopulation between the control and IH-exposure groups. To select differentially expressed genes in each endothelial subpopulation, the cutoff was set as BHQ &lt; 0.2 and fold change &gt; 1.2 (or log2[fold change] &gt; 0.26). Those differential expression genes (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3c</xref>) in endothelial capillary cells were used for BP enrichment analysis in the DAVID database. Selecting and aggregating biological processes (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3d</xref>) were performed as described in the Materials and methods section labeled, ‘Bulk RNA sequencing and analysis’. Transcription factor analysis for capillary aerocytes and general capillary cells were run using SINCERA (<xref ref-type="bibr" rid="bib40">Guo et al., 2015</xref>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016563">SCR_016563</ext-link>). The analysis for control vs IH-exposure groups were run separately. All cells from the three biological replicates were used for a combined analysis. Cell annotations from AltAnalyze were used to select cells annotated to aerocytes and general capillary cells, respectively. For each cell cluster, we selected for marker genes using the FindMarkers function in Seurat (<xref ref-type="bibr" rid="bib91">Satija et al., 2015</xref>) and filtered with parameters pct.1 ≥ 0.2, avg_log2FC ≥ log(1.5), p_val_adj &lt; 0.1. The filtered marker genes were used as the target genes for driving force analysis in SINCERA. The predicted key TF list for aerocytes and general capillary cells for control and IH-exposure groups are shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3e, f</xref>. A network regulatory figure is plotted using igraph (<xref ref-type="bibr" rid="bib18">Csardi and Nepusz, 2006</xref>) package in R. The top 25 predicted TFs from control and IH-exposure groups were selected.</p></sec><sec id="s4-9"><title>Association analysis on IH-responsive genes with pulmonary disease genes and drug targets at the cell-type level</title><p>Gene–disease association information was downloaded from the DisGeNET (<xref ref-type="bibr" rid="bib85">Piñero et al., 2017</xref>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006178">SCR_006178</ext-link>) database (curated gene–disease associations). The downloaded file was filtered with keywords to specifically select genes linked to pulmonary diseases, which includes ‘allergic asthma’, ‘asthma’, ‘chronic obstructive airway disease’, ‘pulmonary hypertension’, ‘chronic thromboembolic pulmonary hypertension’, ‘idiopathic pulmonary arterial hypertension’, ‘familial primary pulmonary hypertension’, ‘idiopathic pulmonary hypertension’, ‘interstitial lung fibrosis’, ‘pulmonary fibrosis’, and ‘idiopathic pulmonary fibrosis’. One-tailed Fisher’s exact test was used to determine whether the top 200 up- or downregulated genes in each cell type exposed to IH significantly overlapped with these pulmonary disease-associated genes (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4a</xref>). The significant cutoff was set with a BH adjusted p-value from a Fisher’s exact test of &lt;0.05 and at least five overlapped genes with any pulmonary disease gene set. For the association analysis between IH-responsive genes and pulmonary drug targets, the xml file was downloaded from the DrugBank (<xref ref-type="bibr" rid="bib115">Wishart et al., 2008</xref>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002700">SCR_002700</ext-link>) (version 5.1.4). The drugbankR package (<ext-link ext-link-type="uri" xlink:href="https://github.com/yduan004/drugbankR">https://github.com/yduan004/drugbankR</ext-link>; <xref ref-type="bibr" rid="bib24">Duan, 2019</xref>) was used to parse the xml file to get each drug and its target genes. The parsed drug table was linked with the top 200 up- or downregulated genes in each cell type exposed to IH by drug target genes. The drug table was further filtered with respiratory tissue and disease-associated key words (e.g. asthma, lung, bronchus, airway, etc.) to keep candidate drugs used to treat pulmonary diseases. The filtered table was manually curated to select drugs mainly indicated to treat pulmonary diseases. In the association analysis, the ‘homologene’ package (<ext-link ext-link-type="uri" xlink:href="https://github.com/oganm/homologene">https://github.com/oganm/homologene</ext-link>; <xref ref-type="bibr" rid="bib69">Mancarci, 2019</xref>) was used to find the human-unique homolog of mouse genes. CellPhoneDB (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017054">SCR_017054</ext-link>) is used to predict ligand–receptor interactions between cell types. The pulmonary disease-relevant drug-targeted gene list (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4b</xref>) is used to select ligand–receptor interaction pairs. Genes with unknown drug effects were filtered out from the analysis. Human homolog gene is used for this analysis. Gain of interactions and loss of interactions are calculated by summing up the number of ligand–receptor interactions that were only significantly present in either hypoxia or control (p-value&lt;0.05 and mean&gt;0.1), respectively, for each cell pair comparison. Two-tailed Fisher’s exact test was used to calculate significance changes of each cell type. Hive plot is made using the HiveR package (<ext-link ext-link-type="uri" xlink:href="https://github.com/bryanhanson/HiveR">https://github.com/bryanhanson/HiveR</ext-link>; <xref ref-type="bibr" rid="bib43">Hanson, 2017</xref>). The gene set enrichment analysis (GSEA; <xref ref-type="bibr" rid="bib99">Subramanian et al., 2005</xref>) was performed for myofibroblasts (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4c</xref>). The expressed genes in myofibroblasts were ranked by the fold change calculated from pseudo-bulk expression values in control and IH-exposure samples. The ‘homologene’ package was used to find the human-unique homolog of correlated mouse genes. The canonical pathway list was downloaded from MSigDB (<ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea/msigdb/collections.jsp">http://www.gsea-msigdb.org/gsea/msigdb/collections.jsp</ext-link>). The fgsea R package (<xref ref-type="bibr" rid="bib57">Korotkevich et al., 2016</xref>) was used to run GSEA on the ranked genes in myofibroblasts. The gene sets were restricted to REACTOME subsets with at least 10 genes but less than 500 genes. The ‘nperm’ was set to 100,000. The significantly enriched gene sets were selected by padj&lt;0.15 and absolute NES values above 1.7. With this cutoff value, no gene sets with downregulated leading edge genes after exposure to IH are significantly enriched. The predicted key TFs for myofibroblasts (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4d</xref>) were performed in a similar way as with endothelial subpopulations. To highlight the IH-driven key TFs, the top 25 TFs predicted from lung myofibroblasts after IH exposure were compared to all significant TFs predicted from lung myofibroblasts in control samples.</p></sec><sec id="s4-10"><title>Lung fixation, histological staining, immunofluorescence, confocal microscopy, and quantification of confocal images</title><p>For histological staining, mice were sacrificed, and lung inflation fixation was immediately performed. After exposure of the trachea and lungs, the trachea was cannulated with a scalp vein cannula (EXELINT, Redondo Beach, CA), and 10% neutral buffered formalin was gravity perfused into the lung at a height of 25 cm. After infusion, the lung was harvested and placed in formalin for 24 hr. Whole lung was then dehydrated in 70% ethanol and embedded in paraffin. For morphologic evaluation, 5 µm thick sections were cut from the paraffin blocks and stained with hematoxylin and eosin.</p><p>Immunofluorescence staining on 10% formalin-fixed mouse lung was performed on 5 µm thick paraffin-embedded tissue sections. Tissue slides were melted at 60°C for 2 hr, following rehydration through xylene and alcohol, and finally in PBS. Antigen retrieval was performed in 0.1 M citrate buffer (pH 6.0) by microwaving. Slides were blocked for 2 hr at room temperature using 4% normal donkey serum in PBS containing 0.2% Triton X-100 and then incubated with primary antibodies diluted in blocking buffer for approximately 16 hr at 4°C. Primary antibodies included ACTA2 (1:2000, Sigma–Aldrich; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_262054">AB_262054</ext-link>), EMCN (1:200, R and D Systems; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2100035">AB_2100035</ext-link>), FOXFI (1:100, R and D Systems; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2105588">AB_2105588</ext-link>), HOPX (1:100, Santa Cruz Biotechnology; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687966">AB_2687966</ext-link>), MKI67 (1:100, BD Biosciences; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_396287">AB_396287</ext-link>), POSTN (1:100, ABCAM), Pro-SFTPC (1:1000, Seven Hills Bioreagents; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2335890">AB_2335890</ext-link>), SOX9 (1:100, Millipore; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2239761">AB_2239761</ext-link>), and LYVE1 (1:100, ABCAM; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_301509">AB_301509</ext-link>). Secondary antibodies conjugated to Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 633 were used at a dilution of 1:200 in blocking buffer for 1 hr at room temperature. Nuclei were counterstained with DAPI (1 μg/ml) (ThermoFisher). Sections were mounted using ProLong Gold (ThermoFisher) mounting medium and coverslipped. Tissue sections were then imaged on an inverted Nikon A1R confocal microscope using a NA 1.27 objective using a 1.2 AU pinhole. Maximum-intensity projections of multi-labeled Z-stack images were generated using Nikon NIS-Elements software (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014329">SCR_014329</ext-link>).</p><p>Heterogeneous cell populations from paraffin-embedded immunofluorescent confocal images (60× magnification) were characterized in Imaris (Bitplane; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link>), version 9.6. An average of 185 cells from control mice and 301 cells from IH-treated mice (n = 4 mice, six images per mouse) were counted specifically for proliferating cells (MKI67), endothelial cells (FOXF1), and alveolar type II cells (SFTPC) using spot detection or manual counting of cells. The cell percentage endothelial cells was calculated as the ratio between cells stained with FOXF1 and totally counted nucleus stained with DAPI in each image. Similarly, we got the cell percentages of AT2 and proliferating cells. All the remaining cells without FOXF1, SFTPC, and MKI67 staining or a cell stained with both MIK67 and SFTPC were taken as one composition group in the composition difference analysis. For testing the composition difference of endothelial, AT2, and proliferating cells in mouse lung between experimental and control groups, a centered log ratio transformation was performed on the percentage of each cell type before applying the t-test (two tailed). The statistical p-value from the t-test was adjusted with the BH method.</p><p>Alveolar wall thickness was quantified in Imaris (Bitplane), version 9.6, using the measurement tool for autofluorescence to define the alveolar walls. A total of 20 alveolar wall thickness measurements were taken for each 60× magnification confocal image (n = 2 mice per treatment, six images per mouse). Alveolar area and MaxFeret90 area were quantified in Nikon Elements, version 4.5. Maxferet90 is the distance measured orthogonally to the maximum feret chord. The larger Maxferet90 value indicates more openness in the alveolus. General analysis was run on maximum-intensity projection confocal images (20× magnification), n = 2 mice for control- and IH-treated mice, with three images per mouse. Autofluorescence with the TRITC channel was used to define alveolar areas. Thresholding was turned on, and binary processing was created for inverting, removing objects touching borders, and filtering an object area. Airways, arteries, veins, and alveolar ducts were filtered out using a minimum value of 50 and a maximum value of 4000 using the filter on object area binary. Feature area and MaxFeret90 values were exported using Microsoft Excel.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Kathryn A Wikenheiser-Brokamp for her thoughtful discussion and guidance. We thank Bruce J Aranow, Minzhe Guo, Emily R Miraldi, Yan Xu, Kashish Chetal, and J Matthew Kofron for their thoughtful discussion about this manuscript. We would like to thank S Steven Potter for allowing us to use resources available in his lab. We would also like to thank Kalpana Srivastava for work on sectioning tissue specimens and completing immunofluorescence assays.</p> </ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Validation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Software, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Software, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Software, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Software, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2019-0028) of the Cincinnati Children's Hospital Medical Center.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>This file contains tables a–c (referenced in Materials and methods).</title><p>(a) The alignment statistics of bulk RNA-seq data for IH exposure and control mice. (b) Top 200 up- and downregulated genes in mice lung under IH exposure from the bulk RNA-seq data. (c) DAVID-enriched biological processes and merged categories using top 200 differential expression genes from the bulk RNA-seq data.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63003-supp1-v3.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>This file contains tables a–e (referenced in Materials and methods).</title><p>(a) The alignment statistics of scRNA-seq data for IH exposure and control mice. (b) The marker genes list for 25 clusters from AltAnalyze analysis of scRNA-seq data from IH exposure mice. (c) The annotated cell types for 25 cellHarmony aligned clusters of scRNA-seq data from IH exposure and control mice. (d) Top 200 up- and downregulated genes in 19 detected lung cell types under IH exposure from the scRNA-seq data. (e) DAVID-enriched biological processes and merged categories using top 200 differential expression genes in each lung cell type under IH exposure.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63003-supp2-v3.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>This file contains tables a–f (referenced in Materials and methods).</title><p>(a) The marker genes list for six clusters from AltAnalyze analysis of scRNA-seq data from annotated vascular endothelial cells of IH exposure mice. (b) The annotated endothelial subpopulations for six cellHarmony aligned clusters of scRNA-seq data from annotated vascular endothelial cells of IH exposure and control mice. (c) Differential expression genes of four annotated endothelial subpopulations under IH exposure from the scRNA-seq data. (d) DAVID-enriched biological processes and merged categories using differential expression genes of lung capillary cells under IH exposure. (e) Ranking of predicted transcription factors in capillary aerocytes using SINCERA. (f) Ranking of predicted transcription factors in general capillary cells using SINCERA.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63003-supp3-v3.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>This file contains tables a–d (referenced in Materials and methods).</title><p>(a) The pulmonary disease-associated genes from top 200 up- or downregulated genes in each detected lung cell type exposed to IH. (b) The drug table linking drugs mainly indicated to treat pulmonary diseases and top 200 up- or downregulated genes in each cell type exposed to IH. (c) Gene set enrichment analysis of expressed genes in myofibroblasts in mice lung exposed to IH compared to controls. (d) Ranking of predicted transcription factors in myofibroblasts using SINCERA.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63003-supp4-v3.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-63003-transrepform-v3.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data has been uploaded to GEO (GSE145436), as mentioned in the manuscript 'Data and Materials Availability' section.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Yin Yeng</surname><given-names>L</given-names></name><name><surname>Gulla</surname><given-names>EM</given-names></name><name><surname>Potter</surname><given-names>A</given-names></name><name><surname>Kitzmiller</surname><given-names>J</given-names></name><name><surname>Ruben</surname><given-names>MD</given-names></name><name><surname>Salomonis</surname><given-names>N</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Francey</surname><given-names>LJ</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Smith</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Short-term exposure to intermittent hypoxia in mice leads to changes in gene expression seen in chronic pulmonary disease</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145436">GSE145436</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamovich</surname> <given-names>Y</given-names></name><name><surname>Ladeuix</surname> <given-names>B</given-names></name><name><surname>Golik</surname> <given-names>M</given-names></name><name><surname>Koeners</surname> <given-names>MP</given-names></name><name><surname>Asher</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rhythmic oxygen levels reset circadian clocks through HIF1α</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.014</pub-id><pub-id pub-id-type="pmid">27773695</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aihara</surname> <given-names>K</given-names></name><name><surname>Oga</surname> <given-names>T</given-names></name><name><surname>Harada</surname> <given-names>Y</given-names></name><name><surname>Chihara</surname> <given-names>Y</given-names></name><name><surname>Handa</surname> <given-names>T</given-names></name><name><surname>Tanizawa</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>K</given-names></name><name><surname>Tsuboi</surname> <given-names>T</given-names></name><name><surname>Hitomi</surname> <given-names>T</given-names></name><name><surname>Mishima</surname> <given-names>M</given-names></name><name><surname>Chin</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea</article-title><source>Respiratory Medicine</source><volume>105</volume><fpage>939</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2011.02.016</pub-id><pub-id pub-id-type="pmid">21402472</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>RS</given-names></name><name><surname>Kimball</surname> <given-names>TR</given-names></name><name><surname>Bean</surname> <given-names>JA</given-names></name><name><surname>Jeffries</surname> <given-names>JL</given-names></name><name><surname>Willging</surname> <given-names>JP</given-names></name><name><surname>Cotton</surname> <given-names>RT</given-names></name><name><surname>Witt</surname> <given-names>SA</given-names></name><name><surname>Glascock</surname> <given-names>BJ</given-names></name><name><surname>Daniels</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>165</volume><fpage>1395</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1164/rccm.2105118</pub-id><pub-id pub-id-type="pmid">12016102</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>RS</given-names></name><name><surname>Carroll</surname> <given-names>JL</given-names></name><name><surname>Jeffries</surname> <given-names>JL</given-names></name><name><surname>Grone</surname> <given-names>C</given-names></name><name><surname>Bean</surname> <given-names>JA</given-names></name><name><surname>Chini</surname> <given-names>B</given-names></name><name><surname>Bokulic</surname> <given-names>R</given-names></name><name><surname>Daniels</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>169</volume><fpage>950</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1164/rccm.200309-1305OC</pub-id><pub-id pub-id-type="pmid">14764433</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>RS</given-names></name><name><surname>Kimball</surname> <given-names>TR</given-names></name><name><surname>Kalra</surname> <given-names>M</given-names></name><name><surname>Jeffries</surname> <given-names>JL</given-names></name><name><surname>Carroll</surname> <given-names>JL</given-names></name><name><surname>Bean</surname> <given-names>JA</given-names></name><name><surname>Witt</surname> <given-names>SA</given-names></name><name><surname>Glascock</surname> <given-names>BJ</given-names></name><name><surname>Daniels</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Left ventricular function in children with sleep-disordered breathing</article-title><source>The American Journal of Cardiology</source><volume>95</volume><fpage>801</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2004.11.044</pub-id><pub-id pub-id-type="pmid">15757619</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Pyl</surname> <given-names>PT</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjafield</surname> <given-names>AV</given-names></name><name><surname>Ayas</surname> <given-names>NT</given-names></name><name><surname>Eastwood</surname> <given-names>PR</given-names></name><name><surname>Heinzer</surname> <given-names>R</given-names></name><name><surname>Ip</surname> <given-names>MSM</given-names></name><name><surname>Morrell</surname> <given-names>MJ</given-names></name><name><surname>Nunez</surname> <given-names>CM</given-names></name><name><surname>Patel</surname> <given-names>SR</given-names></name><name><surname>Penzel</surname> <given-names>T</given-names></name><name><surname>Pépin</surname> <given-names>JL</given-names></name><name><surname>Peppard</surname> <given-names>PE</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name><name><surname>Tufik</surname> <given-names>S</given-names></name><name><surname>Valentine</surname> <given-names>K</given-names></name><name><surname>Malhotra</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis</article-title><source>The Lancet Respiratory Medicine</source><volume>7</volume><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(19)30198-5</pub-id><pub-id pub-id-type="pmid">31300334</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y</given-names></name><name><surname>Hochberg</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society: Series B</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharjee</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Alotaibi</surname> <given-names>WH</given-names></name><name><surname>Kheirandish-Gozal</surname> <given-names>L</given-names></name><name><surname>Capdevila</surname> <given-names>OS</given-names></name><name><surname>Gozal</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea</article-title><source>Chest</source><volume>141</volume><fpage>682</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1378/chest.11-1777</pub-id><pub-id pub-id-type="pmid">22030801</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname> <given-names>MP</given-names></name><name><surname>Smales</surname> <given-names>C</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Hussain</surname> <given-names>MV</given-names></name><name><surname>Mohamed</surname> <given-names>YA</given-names></name><name><surname>Morimoto</surname> <given-names>M</given-names></name><name><surname>Shea</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The circadian system contributes to apnea lengthening across the night in obstructive sleep apnea</article-title><source>Sleep</source><volume>38</volume><fpage>1793</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.5665/sleep.5166</pub-id><pub-id pub-id-type="pmid">26039970</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos-Rodriguez</surname> <given-names>F</given-names></name><name><surname>Martinez-Garcia</surname> <given-names>MA</given-names></name><name><surname>Martinez</surname> <given-names>M</given-names></name><name><surname>Duran-Cantolla</surname> <given-names>J</given-names></name><name><surname>Peña</surname> <given-names>ML</given-names></name><name><surname>Masdeu</surname> <given-names>MJ</given-names></name><name><surname>Gonzalez</surname> <given-names>M</given-names></name><name><surname>Campo</surname> <given-names>F</given-names></name><name><surname>Gallego</surname> <given-names>I</given-names></name><name><surname>Marin</surname> <given-names>JM</given-names></name><name><surname>Barbe</surname> <given-names>F</given-names></name><name><surname>Montserrat</surname> <given-names>JM</given-names></name><name><surname>Farre</surname> <given-names>R</given-names></name><collab>Spanish Sleep Network</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Association between obstructive sleep apnea and Cancer incidence in a large multicenter Spanish cohort</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>187</volume><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1164/rccm.201209-1671OC</pub-id><pub-id pub-id-type="pmid">23155146</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalacheva</surname> <given-names>P</given-names></name><name><surname>Thum</surname> <given-names>J</given-names></name><name><surname>Yokoe</surname> <given-names>T</given-names></name><name><surname>O'Donnell</surname> <given-names>CP</given-names></name><name><surname>Khoo</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Development of autonomic dysfunction with intermittent hypoxia in a lean murine model</article-title><source>Respiratory Physiology &amp; Neurobiology</source><volume>188</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2013.06.002</pub-id><pub-id pub-id-type="pmid">23774144</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaouat</surname> <given-names>A</given-names></name><name><surname>Weitzenblum</surname> <given-names>E</given-names></name><name><surname>Krieger</surname> <given-names>J</given-names></name><name><surname>Oswald</surname> <given-names>M</given-names></name><name><surname>Kessler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Pulmonary hemodynamics in the obstructive sleep apnea syndrome. results in 220 consecutive patients</article-title><source>Chest</source><volume>109</volume><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1378/chest.109.2.380</pub-id><pub-id pub-id-type="pmid">8620709</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charpentier</surname> <given-names>MS</given-names></name><name><surname>Christine</surname> <given-names>KS</given-names></name><name><surname>Amin</surname> <given-names>NM</given-names></name><name><surname>Dorr</surname> <given-names>KM</given-names></name><name><surname>Kushner</surname> <given-names>EJ</given-names></name><name><surname>Bautch</surname> <given-names>VL</given-names></name><name><surname>Taylor</surname> <given-names>JM</given-names></name><name><surname>Conlon</surname> <given-names>FL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway</article-title><source>Developmental Cell</source><volume>25</volume><fpage>132</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.03.003</pub-id><pub-id pub-id-type="pmid">23639441</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Bardes</surname> <given-names>EE</given-names></name><name><surname>Aronow</surname> <given-names>BJ</given-names></name><name><surname>Jegga</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ToppGene suite for gene list enrichment analysis and candidate gene prioritization</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>W305</fpage><lpage>W311</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp427</pub-id><pub-id pub-id-type="pmid">19465376</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname> <given-names>K</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Shimizu</surname> <given-names>K</given-names></name><name><surname>Mishima</surname> <given-names>M</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Miyasaka</surname> <given-names>M</given-names></name><name><surname>Ohi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome</article-title><source>The American Journal of Medicine</source><volume>109</volume><fpage>562</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/S0002-9343(00)00580-5</pub-id><pub-id pub-id-type="pmid">11063958</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossland</surname> <given-names>RF</given-names></name><name><surname>Durgan</surname> <given-names>DJ</given-names></name><name><surname>Lloyd</surname> <given-names>EE</given-names></name><name><surname>Phillips</surname> <given-names>SC</given-names></name><name><surname>Reddy</surname> <given-names>AK</given-names></name><name><surname>Marrelli</surname> <given-names>SP</given-names></name><name><surname>Bryan</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A new rodent model for obstructive sleep apnea: effects on ATP-mediated dilations in cerebral arteries</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>305</volume><fpage>R334</fpage><lpage>R342</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00244.2013</pub-id><pub-id pub-id-type="pmid">23761641</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csardi</surname> <given-names>G</given-names></name><name><surname>Nepusz</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The igraph software package for complex network research</article-title><source>InterJournal, Complex Systems</source><volume>1695</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cubillos-Zapata</surname> <given-names>C</given-names></name><name><surname>Avendaño-Ortiz</surname> <given-names>J</given-names></name><name><surname>Hernandez-Jimenez</surname> <given-names>E</given-names></name><name><surname>Toledano</surname> <given-names>V</given-names></name><name><surname>Casas-Martin</surname> <given-names>J</given-names></name><name><surname>Varela-Serrano</surname> <given-names>A</given-names></name><name><surname>Torres</surname> <given-names>M</given-names></name><name><surname>Almendros</surname> <given-names>I</given-names></name><name><surname>Casitas</surname> <given-names>R</given-names></name><name><surname>Fernández-Navarro</surname> <given-names>I</given-names></name><name><surname>Garcia-Sanchez</surname> <given-names>A</given-names></name><name><surname>Aguirre</surname> <given-names>LA</given-names></name><name><surname>Farre</surname> <given-names>R</given-names></name><name><surname>López-Collazo</surname> <given-names>E</given-names></name><name><surname>García-Rio</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea</article-title><source>European Respiratory Journal</source><volume>50</volume><elocation-id>1700833</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.00833-2017</pub-id><pub-id pub-id-type="pmid">29051270</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname> <given-names>PS</given-names></name><name><surname>Meijer</surname> <given-names>P</given-names></name><name><surname>Nazgiewicz</surname> <given-names>A</given-names></name><name><surname>Anderson</surname> <given-names>SG</given-names></name><name><surname>Borthwick</surname> <given-names>LA</given-names></name><name><surname>Bagnall</surname> <given-names>J</given-names></name><name><surname>Kitchen</surname> <given-names>GB</given-names></name><name><surname>Lodyga</surname> <given-names>M</given-names></name><name><surname>Begley</surname> <given-names>N</given-names></name><name><surname>Venkateswaran</surname> <given-names>RV</given-names></name><name><surname>Shah</surname> <given-names>R</given-names></name><name><surname>Mercer</surname> <given-names>PF</given-names></name><name><surname>Durrington</surname> <given-names>HJ</given-names></name><name><surname>Henderson</surname> <given-names>NC</given-names></name><name><surname>Piper-Hanley</surname> <given-names>K</given-names></name><name><surname>Fisher</surname> <given-names>AJ</given-names></name><name><surname>Chambers</surname> <given-names>RC</given-names></name><name><surname>Bechtold</surname> <given-names>DA</given-names></name><name><surname>Gibbs</surname> <given-names>JE</given-names></name><name><surname>Loudon</surname> <given-names>AS</given-names></name><name><surname>Rutter</surname> <given-names>MK</given-names></name><name><surname>Hinz</surname> <given-names>B</given-names></name><name><surname>Ray</surname> <given-names>DW</given-names></name><name><surname>Blaikley</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The circadian clock protein reverbα inhibits pulmonary fibrosis development</article-title><source>PNAS</source><volume>117</volume><fpage>1139</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912109117</pub-id><pub-id pub-id-type="pmid">31879343</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DePasquale</surname> <given-names>EAK</given-names></name><name><surname>Schnell</surname> <given-names>D</given-names></name><name><surname>Dexheimer</surname> <given-names>P</given-names></name><name><surname>Ferchen</surname> <given-names>K</given-names></name><name><surname>Hay</surname> <given-names>S</given-names></name><name><surname>Chetal</surname> <given-names>K</given-names></name><name><surname>Valiente-Alandí</surname> <given-names>Í</given-names></name><name><surname>Blaxall</surname> <given-names>BC</given-names></name><name><surname>Grimes</surname> <given-names>HL</given-names></name><name><surname>Salomonis</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes</article-title><source>Nucleic Acids Research</source><volume>47</volume><elocation-id>e138</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkz789</pub-id><pub-id pub-id-type="pmid">31529053</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Kitzmiller</surname> <given-names>JA</given-names></name><name><surname>Sridharan</surname> <given-names>A</given-names></name><name><surname>Perl</surname> <given-names>AK</given-names></name><name><surname>Bridges</surname> <given-names>JP</given-names></name><name><surname>Misra</surname> <given-names>RS</given-names></name><name><surname>Pryhuber</surname> <given-names>GS</given-names></name><name><surname>Mariani</surname> <given-names>TJ</given-names></name><name><surname>Bhattacharya</surname> <given-names>S</given-names></name><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name><name><surname>Dexheimer</surname> <given-names>P</given-names></name><name><surname>Aronow</surname> <given-names>B</given-names></name><name><surname>Jobe</surname> <given-names>AH</given-names></name><name><surname>Whitsett</surname> <given-names>JA</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lung gene expression analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development</article-title><source>Thorax</source><volume>72</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2016-209598</pub-id><pub-id pub-id-type="pmid">28070014</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Duan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>drugBankR</data-title><source>GitHub</source><version designator="1.5">1.5</version><ext-link ext-link-type="uri" xlink:href="https://github.com/yduan004/drugbankR">https://github.com/yduan004/drugbankR</ext-link></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>RS</given-names></name><name><surname>Green</surname> <given-names>EW</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>van Ooijen</surname> <given-names>G</given-names></name><name><surname>Olmedo</surname> <given-names>M</given-names></name><name><surname>Qin</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Pan</surname> <given-names>M</given-names></name><name><surname>Valekunja</surname> <given-names>UK</given-names></name><name><surname>Feeney</surname> <given-names>KA</given-names></name><name><surname>Maywood</surname> <given-names>ES</given-names></name><name><surname>Hastings</surname> <given-names>MH</given-names></name><name><surname>Baliga</surname> <given-names>NS</given-names></name><name><surname>Merrow</surname> <given-names>M</given-names></name><name><surname>Millar</surname> <given-names>AJ</given-names></name><name><surname>Johnson</surname> <given-names>CH</given-names></name><name><surname>Kyriacou</surname> <given-names>CP</given-names></name><name><surname>O'Neill</surname> <given-names>JS</given-names></name><name><surname>Reddy</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Peroxiredoxins are conserved markers of circadian rhythms</article-title><source>Nature</source><volume>485</volume><fpage>459</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nature11088</pub-id><pub-id pub-id-type="pmid">22622569</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltzschig</surname> <given-names>HK</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hypoxia and inflammation</article-title><source>New England Journal of Medicine</source><volume>364</volume><fpage>656</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1056/NEJMra0910283</pub-id><pub-id pub-id-type="pmid">21323543</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname> <given-names>PL</given-names></name><name><surname>Goodwin</surname> <given-names>JL</given-names></name><name><surname>Sherrill</surname> <given-names>DL</given-names></name><name><surname>Quan</surname> <given-names>JR</given-names></name><name><surname>Quan</surname> <given-names>SF</given-names></name><collab>Tucson Children's Assessment of Sleep Apnea study</collab></person-group><year iso-8601-date="2003">2003</year><article-title>Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and hispanic children: the Tucson children's Assessment of Sleep Apnea study</article-title><source>Archives of Pediatrics &amp; Adolescent Medicine</source><volume>157</volume><fpage>901</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1001/archpedi.157.9.901</pub-id><pub-id pub-id-type="pmid">12963596</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entzian</surname> <given-names>P</given-names></name><name><surname>Linnemann</surname> <given-names>K</given-names></name><name><surname>Schlaak</surname> <given-names>M</given-names></name><name><surname>Zabel</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>153</volume><fpage>1080</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.153.3.8630548</pub-id><pub-id pub-id-type="pmid">8630548</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farber</surname> <given-names>HW</given-names></name><name><surname>Gin-Sing</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Practical considerations for therapies targeting the prostacyclin pathway</article-title><source>European Respiratory Review</source><volume>25</volume><fpage>418</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1183/16000617.0083-2016</pub-id><pub-id pub-id-type="pmid">27903664</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farré</surname> <given-names>R</given-names></name><name><surname>Montserrat</surname> <given-names>JM</given-names></name><name><surname>Gozal</surname> <given-names>D</given-names></name><name><surname>Almendros</surname> <given-names>I</given-names></name><name><surname>Navajas</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intermittent hypoxia severity in animal models of sleep apnea</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1556</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01556</pub-id><pub-id pub-id-type="pmid">30459638</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname> <given-names>CB</given-names></name><name><surname>Schoorlemmer</surname> <given-names>GH</given-names></name><name><surname>Rocha</surname> <given-names>AA</given-names></name><name><surname>Cravo</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Increased sympathetic responses induced by chronic obstructive sleep apnea are caused by sleep fragmentation</article-title><source>Journal of Applied Physiology</source><volume>129</volume><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00811.2019</pub-id><pub-id pub-id-type="pmid">32552428</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabryelska</surname> <given-names>A</given-names></name><name><surname>Sochal</surname> <given-names>M</given-names></name><name><surname>Turkiewicz</surname> <given-names>S</given-names></name><name><surname>Białasiewicz</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Relationship between HIF-1 and circadian clock proteins in obstructive sleep apnea Patients—Preliminary Study</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>1599</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9051599</pub-id><pub-id pub-id-type="pmid">32466207</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallego-Martin</surname> <given-names>T</given-names></name><name><surname>Farré</surname> <given-names>R</given-names></name><name><surname>Almendros</surname> <given-names>I</given-names></name><name><surname>Gonzalez-Obeso</surname> <given-names>E</given-names></name><name><surname>Obeso</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice</article-title><source>European Respiratory Journal</source><volume>49</volume><elocation-id>1602111</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.02111-2016</pub-id><pub-id pub-id-type="pmid">28202553</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname> <given-names>JE</given-names></name><name><surname>Beesley</surname> <given-names>S</given-names></name><name><surname>Plumb</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>D</given-names></name><name><surname>Farrow</surname> <given-names>S</given-names></name><name><surname>Ray</surname> <given-names>DW</given-names></name><name><surname>Loudon</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Circadian timing in the lung; a specific role for bronchiolar epithelial cells</article-title><source>Endocrinology</source><volume>150</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1210/en.2008-0638</pub-id><pub-id pub-id-type="pmid">18787022</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gille</surname> <given-names>T</given-names></name><name><surname>Didier</surname> <given-names>M</given-names></name><name><surname>Rotenberg</surname> <given-names>C</given-names></name><name><surname>Delbrel</surname> <given-names>E</given-names></name><name><surname>Marchant</surname> <given-names>D</given-names></name><name><surname>Sutton</surname> <given-names>A</given-names></name><name><surname>Dard</surname> <given-names>N</given-names></name><name><surname>Haine</surname> <given-names>L</given-names></name><name><surname>Voituron</surname> <given-names>N</given-names></name><name><surname>Bernaudin</surname> <given-names>JF</given-names></name><name><surname>Valeyre</surname> <given-names>D</given-names></name><name><surname>Nunes</surname> <given-names>H</given-names></name><name><surname>Besnard</surname> <given-names>V</given-names></name><name><surname>Boncoeur</surname> <given-names>E</given-names></name><name><surname>Planès</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intermittent hypoxia increases the severity of Bleomycin-Induced lung injury in mice</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2018</volume><elocation-id>1240192</elocation-id><pub-id pub-id-type="doi">10.1155/2018/1240192</pub-id><pub-id pub-id-type="pmid">29725493</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillich</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Farmer</surname> <given-names>CG</given-names></name><name><surname>Travaglini</surname> <given-names>KJ</given-names></name><name><surname>Tan</surname> <given-names>SY</given-names></name><name><surname>Gu</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Feinstein</surname> <given-names>JA</given-names></name><name><surname>Krasnow</surname> <given-names>MA</given-names></name><name><surname>Metzger</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Capillary cell-type specialization in the alveolus</article-title><source>Nature</source><volume>586</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2822-7</pub-id><pub-id pub-id-type="pmid">33057196</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname> <given-names>DJ</given-names></name><name><surname>Yenokyan</surname> <given-names>G</given-names></name><name><surname>Newman</surname> <given-names>AB</given-names></name><name><surname>O'Connor</surname> <given-names>GT</given-names></name><name><surname>Punjabi</surname> <given-names>NM</given-names></name><name><surname>Quan</surname> <given-names>SF</given-names></name><name><surname>Redline</surname> <given-names>S</given-names></name><name><surname>Resnick</surname> <given-names>HE</given-names></name><name><surname>Tong</surname> <given-names>EK</given-names></name><name><surname>Diener-West</surname> <given-names>M</given-names></name><name><surname>Shahar</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study</article-title><source>Circulation</source><volume>122</volume><fpage>352</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.901801</pub-id><pub-id pub-id-type="pmid">20625114</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gozal</surname> <given-names>D</given-names></name><name><surname>Serpero</surname> <given-names>LD</given-names></name><name><surname>Sans Capdevila</surname> <given-names>O</given-names></name><name><surname>Kheirandish-Gozal</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Systemic inflammation in non-obese children with obstructive sleep apnea</article-title><source>Sleep Medicine</source><volume>9</volume><fpage>254</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2007.04.013</pub-id><pub-id pub-id-type="pmid">17825619</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>YZ</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Bradfield</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The PAS superfamily: sensors of environmental and developmental signals</article-title><source>Annual Review of Pharmacology and Toxicology</source><volume>40</volume><fpage>519</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.40.1.519</pub-id><pub-id pub-id-type="pmid">10836146</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name><name><surname>Whitsett</surname> <given-names>JA</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SINCERA: a pipeline for Single-Cell RNA-Seq profiling analysis</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004575</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004575</pub-id><pub-id pub-id-type="pmid">26600239</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Gokey</surname> <given-names>JJ</given-names></name><name><surname>Ray</surname> <given-names>S</given-names></name><name><surname>Bell</surname> <given-names>SM</given-names></name><name><surname>Adam</surname> <given-names>M</given-names></name><name><surname>Sudha</surname> <given-names>P</given-names></name><name><surname>Perl</surname> <given-names>AK</given-names></name><name><surname>Deshmukh</surname> <given-names>H</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name><name><surname>Whitsett</surname> <given-names>JA</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single cell RNA analysis identifies cellular heterogeneity and adaptive responses of the lung at birth</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>37</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-07770-1</pub-id><pub-id pub-id-type="pmid">30604742</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habermann</surname> <given-names>AC</given-names></name><name><surname>Gutierrez</surname> <given-names>AJ</given-names></name><name><surname>Bui</surname> <given-names>LT</given-names></name><name><surname>Yahn</surname> <given-names>SL</given-names></name><name><surname>Winters</surname> <given-names>NI</given-names></name><name><surname>Calvi</surname> <given-names>CL</given-names></name><name><surname>Peter</surname> <given-names>L</given-names></name><name><surname>Chung</surname> <given-names>MI</given-names></name><name><surname>Taylor</surname> <given-names>CJ</given-names></name><name><surname>Jetter</surname> <given-names>C</given-names></name><name><surname>Raju</surname> <given-names>L</given-names></name><name><surname>Roberson</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>G</given-names></name><name><surname>Wood</surname> <given-names>L</given-names></name><name><surname>Sucre</surname> <given-names>JMS</given-names></name><name><surname>Richmond</surname> <given-names>BW</given-names></name><name><surname>Serezani</surname> <given-names>AP</given-names></name><name><surname>McDonnell</surname> <given-names>WJ</given-names></name><name><surname>Mallal</surname> <given-names>SB</given-names></name><name><surname>Bacchetta</surname> <given-names>MJ</given-names></name><name><surname>Loyd</surname> <given-names>JE</given-names></name><name><surname>Shaver</surname> <given-names>CM</given-names></name><name><surname>Ware</surname> <given-names>LB</given-names></name><name><surname>Bremner</surname> <given-names>R</given-names></name><name><surname>Walia</surname> <given-names>R</given-names></name><name><surname>Blackwell</surname> <given-names>TS</given-names></name><name><surname>Banovich</surname> <given-names>NE</given-names></name><name><surname>Kropski</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba1972</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1972</pub-id><pub-id pub-id-type="pmid">32832598</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Hanson</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>HiveR</data-title><source>GitHub</source><version designator="0.3.42">0.3.42</version><ext-link ext-link-type="uri" xlink:href="https://github.com/bryanhanson/HiveR">https://github.com/bryanhanson/HiveR</ext-link></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname> <given-names>SH</given-names></name><name><surname>Cho</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP</article-title><source>International Journal of Biological Sciences</source><volume>10</volume><fpage>438</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.7150/ijbs.8095</pub-id><pub-id pub-id-type="pmid">24719561</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersh</surname> <given-names>CP</given-names></name><name><surname>DeMeo</surname> <given-names>DL</given-names></name><name><surname>Raby</surname> <given-names>BA</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Sylvia</surname> <given-names>JS</given-names></name><name><surname>Sparrow</surname> <given-names>D</given-names></name><name><surname>Reilly</surname> <given-names>JJ</given-names></name><name><surname>Silverman</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic linkage and association analysis of COPD-related traits on chromosome 8p</article-title><source>COPD: Journal of Chronic Obstructive Pulmonary Disease</source><volume>3</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1080/15412550601009321</pub-id><pub-id pub-id-type="pmid">17361499</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Gu</surname> <given-names>YZ</given-names></name><name><surname>Jain</surname> <given-names>S</given-names></name><name><surname>Bradfield</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors</article-title><source>PNAS</source><volume>95</volume><fpage>5474</fpage><lpage>5479</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.10.5474</pub-id><pub-id pub-id-type="pmid">9576906</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>daW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idell</surname> <given-names>S</given-names></name><name><surname>Maunder</surname> <given-names>R</given-names></name><name><surname>Fein</surname> <given-names>AM</given-names></name><name><surname>Switalska</surname> <given-names>HI</given-names></name><name><surname>Tuszynski</surname> <given-names>GP</given-names></name><name><surname>McLarty</surname> <given-names>J</given-names></name><name><surname>Niewiarowski</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Platelet-specific alpha-granule proteins and thrombospondin in Bronchoalveolar lavage in the adult respiratory distress syndrome</article-title><source>Chest</source><volume>96</volume><fpage>1125</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1378/chest.96.5.1125</pub-id><pub-id pub-id-type="pmid">2530064</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname> <given-names>J</given-names></name><name><surname>Reinke</surname> <given-names>C</given-names></name><name><surname>Bedja</surname> <given-names>D</given-names></name><name><surname>Berkowitz</surname> <given-names>D</given-names></name><name><surname>Bevans-Fonti</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Barouch</surname> <given-names>LA</given-names></name><name><surname>Gabrielson</surname> <given-names>K</given-names></name><name><surname>Polotsky</surname> <given-names>VY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice</article-title><source>Atherosclerosis</source><volume>209</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2009.10.017</pub-id><pub-id pub-id-type="pmid">19897196</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname> <given-names>JC</given-names></name><name><surname>Shin</surname> <given-names>MK</given-names></name><name><surname>Devera</surname> <given-names>R</given-names></name><name><surname>Yao</surname> <given-names>Q</given-names></name><name><surname>Mesarwi</surname> <given-names>O</given-names></name><name><surname>Bevans-Fonti</surname> <given-names>S</given-names></name><name><surname>Polotsky</surname> <given-names>VY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy</article-title><source>American Journal of Physiology-Endocrinology and Metabolism</source><volume>307</volume><fpage>E1073</fpage><lpage>E1083</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00373.2014</pub-id><pub-id pub-id-type="pmid">25315697</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname> <given-names>VK</given-names></name><name><surname>Auckley</surname> <given-names>DH</given-names></name><name><surname>Chowdhuri</surname> <given-names>S</given-names></name><name><surname>Kuhlmann</surname> <given-names>DC</given-names></name><name><surname>Mehra</surname> <given-names>R</given-names></name><name><surname>Ramar</surname> <given-names>K</given-names></name><name><surname>Harrod</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>0478 clinical practice guideline for diagnostic testing for adult obstructive sleep apnea; AN update for 2016: an american academy of sleep medicine clinical practice guideline</article-title><source>Sleep</source><volume>40</volume><elocation-id>A178</elocation-id><pub-id pub-id-type="doi">10.1093/sleepj/zsx050.477</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheirandish-Gozal</surname> <given-names>L</given-names></name><name><surname>Khalyfa</surname> <given-names>A</given-names></name><name><surname>Gozal</surname> <given-names>D</given-names></name><name><surname>Bhattacharjee</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene</article-title><source>Chest</source><volume>143</volume><fpage>971</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1378/chest.12-2026</pub-id><pub-id pub-id-type="pmid">23328840</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>JS</given-names></name><name><surname>Podolanczuk</surname> <given-names>AJ</given-names></name><name><surname>Borker</surname> <given-names>P</given-names></name><name><surname>Kawut</surname> <given-names>SM</given-names></name><name><surname>Raghu</surname> <given-names>G</given-names></name><name><surname>Kaufman</surname> <given-names>JD</given-names></name><name><surname>Stukovsky</surname> <given-names>KDH</given-names></name><name><surname>Hoffman</surname> <given-names>EA</given-names></name><name><surname>Barr</surname> <given-names>RG</given-names></name><name><surname>Gottlieb</surname> <given-names>DJ</given-names></name><name><surname>Redline</surname> <given-names>SS</given-names></name><name><surname>Lederer</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Obstructive sleep apnea and subclinical interstitial lung disease in the Multi-Ethnic study of atherosclerosis (MESA)</article-title><source>Annals of the American Thoracic Society</source><volume>14</volume><fpage>1786</fpage><lpage>1795</lpage><pub-id pub-id-type="doi">10.1513/AnnalsATS.201701-091OC</pub-id><pub-id pub-id-type="pmid">28613935</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname> <given-names>DP</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Sangoram</surname> <given-names>AM</given-names></name><name><surname>Wilsbacher</surname> <given-names>LD</given-names></name><name><surname>Tanaka</surname> <given-names>M</given-names></name><name><surname>Antoch</surname> <given-names>MP</given-names></name><name><surname>Steeves</surname> <given-names>TD</given-names></name><name><surname>Vitaterna</surname> <given-names>MH</given-names></name><name><surname>Kornhauser</surname> <given-names>JM</given-names></name><name><surname>Lowrey</surname> <given-names>PL</given-names></name><name><surname>Turek</surname> <given-names>FW</given-names></name><name><surname>Takahashi</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Positional cloning of the mouse circadian clock gene</article-title><source>Cell</source><volume>89</volume><fpage>641</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80245-7</pub-id><pub-id pub-id-type="pmid">9160755</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>M</given-names></name><name><surname>Morinibu</surname> <given-names>A</given-names></name><name><surname>Koyasu</surname> <given-names>S</given-names></name><name><surname>Goto</surname> <given-names>Y</given-names></name><name><surname>Hiraoka</surname> <given-names>M</given-names></name><name><surname>Harada</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes</article-title><source>The FEBS Journal</source><volume>284</volume><fpage>3804</fpage><lpage>3816</lpage><pub-id pub-id-type="doi">10.1111/febs.14280</pub-id><pub-id pub-id-type="pmid">28963769</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohyama</surname> <given-names>J</given-names></name><name><surname>Ohinata</surname> <given-names>JS</given-names></name><name><surname>Hasegawa</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Blood pressure in sleep disordered breathing</article-title><source>Archives of Disease in Childhood</source><volume>88</volume><fpage>139</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1136/adc.88.2.139</pub-id><pub-id pub-id-type="pmid">12538317</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Korotkevich</surname> <given-names>G</given-names></name><name><surname>Sukhov</surname> <given-names>V</given-names></name><name><surname>Sergushichev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fast gene set enrichment analysis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/060012</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koshiji</surname> <given-names>M</given-names></name><name><surname>Kageyama</surname> <given-names>Y</given-names></name><name><surname>Pete</surname> <given-names>EA</given-names></name><name><surname>Horikawa</surname> <given-names>I</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Huang</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>HIF-1alpha induces cell cycle arrest by functionally counteracting myc</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>1949</fpage><lpage>1956</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600196</pub-id><pub-id pub-id-type="pmid">15071503</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname> <given-names>C</given-names></name><name><surname>Mason</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Immunolocalization of SPARC, Tenascin, and thrombospondin in pulmonary fibrosis</article-title><source>The American Journal of Pathology</source><volume>147</volume><fpage>1759</fpage><lpage>1769</lpage><pub-id pub-id-type="pmid">7495300</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>DCL</given-names></name><name><surname>Ip</surname> <given-names>MSM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sleep apnoea and immune regulation: the story is only beginning</article-title><source>Respirology</source><volume>24</volume><fpage>624</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1111/resp.13565</pub-id><pub-id pub-id-type="pmid">31004376</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname> <given-names>LH</given-names></name><name><surname>Mason</surname> <given-names>WR</given-names></name><name><surname>Parnell</surname> <given-names>JA</given-names></name><name><surname>Rice</surname> <given-names>TW</given-names></name><name><surname>Loyd</surname> <given-names>JE</given-names></name><name><surname>Milstone</surname> <given-names>AP</given-names></name><name><surname>Collard</surname> <given-names>HR</given-names></name><name><surname>Malow</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Obstructive sleep apnea is common in idiopathic pulmonary fibrosis</article-title><source>Chest</source><volume>136</volume><fpage>772</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1378/chest.08-2776</pub-id><pub-id pub-id-type="pmid">19567497</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederer</surname> <given-names>DJ</given-names></name><name><surname>Jelic</surname> <given-names>S</given-names></name><name><surname>Basner</surname> <given-names>RC</given-names></name><name><surname>Ishizaka</surname> <given-names>A</given-names></name><name><surname>Bhattacharya</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea</article-title><source>European Respiratory Journal</source><volume>33</volume><fpage>793</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1183/09031936.00150708</pub-id><pub-id pub-id-type="pmid">19336590</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Thorne</surname> <given-names>LN</given-names></name><name><surname>Punjabi</surname> <given-names>NM</given-names></name><name><surname>Sun</surname> <given-names>CK</given-names></name><name><surname>Schwartz</surname> <given-names>AR</given-names></name><name><surname>Smith</surname> <given-names>PL</given-names></name><name><surname>Marino</surname> <given-names>RL</given-names></name><name><surname>Rodriguez</surname> <given-names>A</given-names></name><name><surname>Hubbard</surname> <given-names>WC</given-names></name><name><surname>O'Donnell</surname> <given-names>CP</given-names></name><name><surname>Polotsky</surname> <given-names>VY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Intermittent hypoxia induces hyperlipidemia in lean mice</article-title><source>Circulation Research</source><volume>97</volume><fpage>698</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000183879.60089.a9</pub-id><pub-id pub-id-type="pmid">16123334</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Wei</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Ma</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Qian</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung Cancer</article-title><source>Oncology Letters</source><volume>16</volume><fpage>2490</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.3892/ol.2018.8903</pub-id><pub-id pub-id-type="pmid">30013642</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>DC</given-names></name><name><surname>Brady</surname> <given-names>DC</given-names></name><name><surname>Po</surname> <given-names>P</given-names></name><name><surname>Chuang</surname> <given-names>LP</given-names></name><name><surname>Marcondes</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>EY</given-names></name><name><surname>Keenan</surname> <given-names>BT</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Maislin</surname> <given-names>G</given-names></name><name><surname>Galante</surname> <given-names>RJ</given-names></name><name><surname>Pack</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Simulating obstructive sleep apnea patients' oxygenation characteristics into a mouse model of cyclical intermittent hypoxia</article-title><source>Journal of Applied Physiology</source><volume>118</volume><fpage>544</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00629.2014</pub-id><pub-id pub-id-type="pmid">25429097</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>DC</given-names></name><name><surname>Brady</surname> <given-names>DC</given-names></name><name><surname>Soans</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>EY</given-names></name><name><surname>Valverde</surname> <given-names>L</given-names></name><name><surname>Keenan</surname> <given-names>BT</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Kim</surname> <given-names>WY</given-names></name><name><surname>Park</surname> <given-names>MJ</given-names></name><name><surname>Galante</surname> <given-names>R</given-names></name><name><surname>Shackleford</surname> <given-names>JA</given-names></name><name><surname>Pack</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature</article-title><source>Journal of Applied Physiology</source><volume>121</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01040.2015</pub-id><pub-id pub-id-type="pmid">27125850</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Marsboom</surname> <given-names>G</given-names></name><name><surname>Jambusaria</surname> <given-names>A</given-names></name><name><surname>Xiong</surname> <given-names>S</given-names></name><name><surname>Toth</surname> <given-names>PT</given-names></name><name><surname>Benevolenskaya</surname> <given-names>EV</given-names></name><name><surname>Rehman</surname> <given-names>J</given-names></name><name><surname>Malik</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sox17 is required for endothelial regeneration following inflammation-induced vascular injury</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2126</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10134-y</pub-id><pub-id pub-id-type="pmid">31073164</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Mancarci</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>homologene</data-title><source>GitHub</source><version designator="1.5.68">1.5.68</version><ext-link ext-link-type="uri" xlink:href="https://github.com/oganm/homologene">https://github.com/oganm/homologene</ext-link></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manella</surname> <given-names>G</given-names></name><name><surname>Aviram</surname> <given-names>R</given-names></name><name><surname>Bolshette</surname> <given-names>N</given-names></name><name><surname>Muvkadi</surname> <given-names>S</given-names></name><name><surname>Golik</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>DF</given-names></name><name><surname>Asher</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hypoxia induces a time- and tissue-specific response that elicits intertissue circadian clock misalignment</article-title><source>PNAS</source><volume>117</volume><fpage>779</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1073/pnas.1914112117</pub-id><pub-id pub-id-type="pmid">31848250</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcus</surname> <given-names>CL</given-names></name><name><surname>Brooks</surname> <given-names>LJ</given-names></name><name><surname>Draper</surname> <given-names>KA</given-names></name><name><surname>Gozal</surname> <given-names>D</given-names></name><name><surname>Halbower</surname> <given-names>AC</given-names></name><name><surname>Jones</surname> <given-names>J</given-names></name><name><surname>Schechter</surname> <given-names>MS</given-names></name><name><surname>Ward</surname> <given-names>SD</given-names></name><name><surname>Sheldon</surname> <given-names>SH</given-names></name><name><surname>Shiffman</surname> <given-names>RN</given-names></name><name><surname>Lehmann</surname> <given-names>C</given-names></name><name><surname>Spruyt</surname> <given-names>K</given-names></name><collab>American Academy of Pediatrics</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Diagnosis and management of childhood obstructive sleep apnea syndrome</article-title><source>Pediatrics</source><volume>130</volume><elocation-id>e714–755</elocation-id><pub-id pub-id-type="doi">10.1542/peds.2012-1672</pub-id><pub-id pub-id-type="pmid">22926176</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname> <given-names>JM</given-names></name><name><surname>Agusti</surname> <given-names>A</given-names></name><name><surname>Villar</surname> <given-names>I</given-names></name><name><surname>Forner</surname> <given-names>M</given-names></name><name><surname>Nieto</surname> <given-names>D</given-names></name><name><surname>Carrizo</surname> <given-names>SJ</given-names></name><name><surname>Barbé</surname> <given-names>F</given-names></name><name><surname>Vicente</surname> <given-names>E</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Nieto</surname> <given-names>FJ</given-names></name><name><surname>Jelic</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Association between treated and untreated obstructive sleep apnea and risk of hypertension</article-title><source>Jama</source><volume>307</volume><elocation-id>3418</elocation-id><pub-id pub-id-type="doi">10.1001/jama.2012.3418</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname> <given-names>BE</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Bradfield</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mammalian Per-Arnt-Sim proteins in environmental adaptation</article-title><source>Annual Review of Physiology</source><volume>72</volume><fpage>625</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021909-135922</pub-id><pub-id pub-id-type="pmid">20148691</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNicholas</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>180</volume><fpage>692</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1164/rccm.200903-0347PP</pub-id><pub-id pub-id-type="pmid">19628778</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname> <given-names>S</given-names></name><name><surname>Rodrigues</surname> <given-names>R</given-names></name><name><surname>Barros</surname> <given-names>AB</given-names></name><name><surname>Pejanovic</surname> <given-names>N</given-names></name><name><surname>Neves-Costa</surname> <given-names>A</given-names></name><name><surname>Pedroso</surname> <given-names>D</given-names></name><name><surname>Pereira</surname> <given-names>C</given-names></name><name><surname>Fernandes</surname> <given-names>D</given-names></name><name><surname>Rodrigues</surname> <given-names>JV</given-names></name><name><surname>Barbara</surname> <given-names>C</given-names></name><name><surname>Moita</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Changes in expression of the <italic>CLOCK</italic> gene in obstructive sleep apnea syndrome patients are not reverted by continuous positive airway pressure treatment</article-title><source>Frontiers in Medicine</source><volume>4</volume><elocation-id>187</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2017.00187</pub-id><pub-id pub-id-type="pmid">29164122</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname> <given-names>H</given-names></name><name><surname>Shirai</surname> <given-names>M</given-names></name><name><surname>Tsuchimochi</surname> <given-names>H</given-names></name><name><surname>Yoshida</surname> <given-names>K</given-names></name><name><surname>Kuwahira</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A novel system including an N<sub>2</sub> gas generator and an air compressor for inducing intermittent or chronic hypoxia</article-title><source>International Journal of Clinical and Experimental Physiology</source><volume>1</volume><elocation-id>307</elocation-id><pub-id pub-id-type="doi">10.4103/2348-8093.149770</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisbet</surname> <given-names>RE</given-names></name><name><surname>Graves</surname> <given-names>AS</given-names></name><name><surname>Kleinhenz</surname> <given-names>DJ</given-names></name><name><surname>Rupnow</surname> <given-names>HL</given-names></name><name><surname>Reed</surname> <given-names>AL</given-names></name><name><surname>Fan</surname> <given-names>TH</given-names></name><name><surname>Mitchell</surname> <given-names>PO</given-names></name><name><surname>Sutliff</surname> <given-names>RL</given-names></name><name><surname>Hart</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>40</volume><fpage>601</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1165/2008-0145OC</pub-id><pub-id pub-id-type="pmid">18952568</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohga</surname> <given-names>E</given-names></name><name><surname>Nagase</surname> <given-names>T</given-names></name><name><surname>Tomita</surname> <given-names>T</given-names></name><name><surname>Teramoto</surname> <given-names>S</given-names></name><name><surname>Matsuse</surname> <given-names>T</given-names></name><name><surname>Katayama</surname> <given-names>H</given-names></name><name><surname>Ouchi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome</article-title><source>Journal of Applied Physiology</source><volume>87</volume><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1152/jappl.1999.87.1.10</pub-id><pub-id pub-id-type="pmid">10409552</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname> <given-names>DM</given-names></name><name><surname>Itoh</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The fibroblast growth factor signaling pathway</article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>4</volume><fpage>215</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1002/wdev.176</pub-id><pub-id pub-id-type="pmid">25772309</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osorio</surname> <given-names>RS</given-names></name><name><surname>Gumb</surname> <given-names>T</given-names></name><name><surname>Pirraglia</surname> <given-names>E</given-names></name><name><surname>Varga</surname> <given-names>AW</given-names></name><name><surname>Lu</surname> <given-names>SE</given-names></name><name><surname>Lim</surname> <given-names>J</given-names></name><name><surname>Wohlleber</surname> <given-names>ME</given-names></name><name><surname>Ducca</surname> <given-names>EL</given-names></name><name><surname>Koushyk</surname> <given-names>V</given-names></name><name><surname>Glodzik</surname> <given-names>L</given-names></name><name><surname>Mosconi</surname> <given-names>L</given-names></name><name><surname>Ayappa</surname> <given-names>I</given-names></name><name><surname>Rapoport</surname> <given-names>DM</given-names></name><name><surname>de Leon</surname> <given-names>MJ</given-names></name><collab>Alzheimer's Disease Neuroimaging Initiative</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Sleep-disordered breathing advances cognitive decline in the elderly</article-title><source>Neurology</source><volume>84</volume><fpage>1964</fpage><lpage>1971</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001566</pub-id><pub-id pub-id-type="pmid">25878183</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname> <given-names>VM</given-names></name><name><surname>Keenan</surname> <given-names>BT</given-names></name><name><surname>Jackson</surname> <given-names>N</given-names></name><name><surname>Grandner</surname> <given-names>MA</given-names></name><name><surname>Maislin</surname> <given-names>G</given-names></name><name><surname>Teff</surname> <given-names>K</given-names></name><name><surname>Schwab</surname> <given-names>RJ</given-names></name><name><surname>Arnardottir</surname> <given-names>ES</given-names></name><name><surname>Júlíusson</surname> <given-names>S</given-names></name><name><surname>Benediktsdottir</surname> <given-names>B</given-names></name><name><surname>Gislason</surname> <given-names>T</given-names></name><name><surname>Pack</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity</article-title><source>International Journal of Obesity</source><volume>39</volume><fpage>472</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1038/ijo.2014.123</pub-id><pub-id pub-id-type="pmid">25042863</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname> <given-names>CB</given-names></name><name><surname>Levine</surname> <given-names>DC</given-names></name><name><surname>Cedernaes</surname> <given-names>J</given-names></name><name><surname>Taguchi</surname> <given-names>A</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Tsai</surname> <given-names>SJ</given-names></name><name><surname>Bonar</surname> <given-names>NA</given-names></name><name><surname>McNulty</surname> <given-names>MR</given-names></name><name><surname>Ramsey</surname> <given-names>KM</given-names></name><name><surname>Bass</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Circadian clock interaction with HIF1α mediates oxygenic metabolism and anaerobic glycolysis in skeletal muscle</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.010</pub-id><pub-id pub-id-type="pmid">27773696</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perl</surname> <given-names>AK</given-names></name><name><surname>Gale</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>FGF signaling is required for myofibroblast differentiation during alveolar regeneration</article-title><source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source><volume>297</volume><fpage>L299</fpage><lpage>L308</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00008.2009</pub-id><pub-id pub-id-type="pmid">19502291</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyssonnaux</surname> <given-names>C</given-names></name><name><surname>Datta</surname> <given-names>V</given-names></name><name><surname>Cramer</surname> <given-names>T</given-names></name><name><surname>Doedens</surname> <given-names>A</given-names></name><name><surname>Theodorakis</surname> <given-names>EA</given-names></name><name><surname>Gallo</surname> <given-names>RL</given-names></name><name><surname>Hurtado-Ziola</surname> <given-names>N</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name><name><surname>Johnson</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>HIF-1alpha expression regulates the bactericidal capacity of phagocytes</article-title><source>Journal of Clinical Investigation</source><volume>115</volume><fpage>1806</fpage><lpage>1815</lpage><pub-id pub-id-type="doi">10.1172/JCI23865</pub-id><pub-id pub-id-type="pmid">16007254</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piñero</surname> <given-names>J</given-names></name><name><surname>Bravo</surname> <given-names>À</given-names></name><name><surname>Queralt-Rosinach</surname> <given-names>N</given-names></name><name><surname>Gutiérrez-Sacristán</surname> <given-names>A</given-names></name><name><surname>Deu-Pons</surname> <given-names>J</given-names></name><name><surname>Centeno</surname> <given-names>E</given-names></name><name><surname>García-García</surname> <given-names>J</given-names></name><name><surname>Sanz</surname> <given-names>F</given-names></name><name><surname>Furlong</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D833</fpage><lpage>D839</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw943</pub-id><pub-id pub-id-type="pmid">27924018</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plasschaert</surname> <given-names>LW</given-names></name><name><surname>Žilionis</surname> <given-names>R</given-names></name><name><surname>Choo-Wing</surname> <given-names>R</given-names></name><name><surname>Savova</surname> <given-names>V</given-names></name><name><surname>Knehr</surname> <given-names>J</given-names></name><name><surname>Roma</surname> <given-names>G</given-names></name><name><surname>Klein</surname> <given-names>AM</given-names></name><name><surname>Jaffe</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte</article-title><source>Nature</source><volume>560</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0394-6</pub-id><pub-id pub-id-type="pmid">30069046</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjabi</surname> <given-names>NM</given-names></name><name><surname>Beamer</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Alterations in glucose disposal in Sleep-disordered breathing</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>179</volume><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1164/rccm.200809-1392OC</pub-id><pub-id pub-id-type="pmid">19011148</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname> <given-names>C</given-names></name><name><surname>Bevans-Fonti</surname> <given-names>S</given-names></name><name><surname>Drager</surname> <given-names>LF</given-names></name><name><surname>Shin</surname> <given-names>MK</given-names></name><name><surname>Polotsky</surname> <given-names>VY</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes</article-title><source>Journal of Applied Physiology</source><volume>111</volume><fpage>881</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00492.2011</pub-id><pub-id pub-id-type="pmid">21737828</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname> <given-names>C</given-names></name><name><surname>Bevans-Fonti</surname> <given-names>S</given-names></name><name><surname>Grigoryev</surname> <given-names>DN</given-names></name><name><surname>Drager</surname> <given-names>LF</given-names></name><name><surname>Myers</surname> <given-names>AC</given-names></name><name><surname>Wise</surname> <given-names>RA</given-names></name><name><surname>Schwartz</surname> <given-names>AR</given-names></name><name><surname>Mitzner</surname> <given-names>W</given-names></name><name><surname>Polotsky</surname> <given-names>VY</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Chronic intermittent hypoxia induces lung growth in adult mice</article-title><source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source><volume>300</volume><fpage>L266</fpage><lpage>L273</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00239.2010</pub-id><pub-id pub-id-type="pmid">21131398</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajkov</surname> <given-names>D</given-names></name><name><surname>McEvoy</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Obstructive sleep apnea and pulmonary hypertension</article-title><source>Progress in Cardiovascular Diseases</source><volume>51</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.pcad.2008.06.001</pub-id><pub-id pub-id-type="pmid">19249442</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Farrell</surname> <given-names>JA</given-names></name><name><surname>Gennert</surname> <given-names>D</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Spatial reconstruction of single-cell gene expression data</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id><pub-id pub-id-type="pmid">25867923</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholz</surname> <given-names>CC</given-names></name><name><surname>Taylor</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeting the HIF pathway in inflammation and immunity</article-title><source>Current Opinion in Pharmacology</source><volume>13</volume><fpage>646</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2013.04.009</pub-id><pub-id pub-id-type="pmid">23660374</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>R</given-names></name><name><surname>Murzabekova</surname> <given-names>G</given-names></name><name><surname>Egemnazarov</surname> <given-names>B</given-names></name><name><surname>Kraut</surname> <given-names>S</given-names></name><name><surname>Eisele</surname> <given-names>H-J</given-names></name><name><surname>Dumitrascu</surname> <given-names>R</given-names></name><name><surname>Heitmann</surname> <given-names>J</given-names></name><name><surname>Seimetz</surname> <given-names>M</given-names></name><name><surname>Witzenrath</surname> <given-names>M</given-names></name><name><surname>Ghofrani</surname> <given-names>HA</given-names></name><name><surname>Schermuly</surname> <given-names>RT</given-names></name><name><surname>Grimminger</surname> <given-names>F</given-names></name><name><surname>Seeger</surname> <given-names>W</given-names></name><name><surname>Weissmann</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Arterial hypertension in a murine model of sleep apnea</article-title><source>Journal of Hypertension</source><volume>32</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000000016</pub-id><pub-id pub-id-type="pmid">24270180</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiraishi</surname> <given-names>T</given-names></name><name><surname>Verdone</surname> <given-names>JE</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Kahlert</surname> <given-names>UD</given-names></name><name><surname>Hernandez</surname> <given-names>JR</given-names></name><name><surname>Torga</surname> <given-names>G</given-names></name><name><surname>Zarif</surname> <given-names>JC</given-names></name><name><surname>Epstein</surname> <given-names>T</given-names></name><name><surname>Gatenby</surname> <given-names>R</given-names></name><name><surname>McCartney</surname> <given-names>A</given-names></name><name><surname>Elisseeff</surname> <given-names>JH</given-names></name><name><surname>Mooney</surname> <given-names>SM</given-names></name><name><surname>An</surname> <given-names>SS</given-names></name><name><surname>Pienta</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast Cancer cells</article-title><source>Oncotarget</source><volume>6</volume><fpage>130</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.2766</pub-id><pub-id pub-id-type="pmid">25426557</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname> <given-names>EK</given-names></name><name><surname>Palmer</surname> <given-names>LJ</given-names></name><name><surname>Mosley</surname> <given-names>JD</given-names></name><name><surname>Barth</surname> <given-names>M</given-names></name><name><surname>Senter</surname> <given-names>JM</given-names></name><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Drazen</surname> <given-names>JM</given-names></name><name><surname>Kwiatkowski</surname> <given-names>DJ</given-names></name><name><surname>Chapman</surname> <given-names>HA</given-names></name><name><surname>Campbell</surname> <given-names>EJ</given-names></name><name><surname>Province</surname> <given-names>MA</given-names></name><name><surname>Rao</surname> <given-names>DC</given-names></name><name><surname>Reilly</surname> <given-names>JJ</given-names></name><name><surname>Ginns</surname> <given-names>LC</given-names></name><name><surname>Speizer</surname> <given-names>FE</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease</article-title><source>The American Journal of Human Genetics</source><volume>70</volume><fpage>1229</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1086/340316</pub-id><pub-id pub-id-type="pmid">11914989</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitbon</surname> <given-names>O</given-names></name><name><surname>Vonk Noordegraaf</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience</article-title><source>European Respiratory Review</source><volume>26</volume><elocation-id>160055</elocation-id><pub-id pub-id-type="doi">10.1183/16000617.0055-2016</pub-id><pub-id pub-id-type="pmid">28096285</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitkovsky</surname> <given-names>MV</given-names></name><name><surname>Kjaergaard</surname> <given-names>J</given-names></name><name><surname>Lukashev</surname> <given-names>D</given-names></name><name><surname>Ohta</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia</article-title><source>Clinical Cancer Research</source><volume>14</volume><fpage>5947</fpage><lpage>5952</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-0229</pub-id><pub-id pub-id-type="pmid">18829471</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>DF</given-names></name><name><surname>Hossain</surname> <given-names>MM</given-names></name><name><surname>Hura</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>G</given-names></name><name><surname>McConnell</surname> <given-names>K</given-names></name><name><surname>Ishman</surname> <given-names>SL</given-names></name><name><surname>Amin</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inflammatory milieu and cardiovascular homeostasis in children with Obstructive Sleep Apnea</article-title><source>Sleep</source><volume>40</volume><elocation-id>zsx022</elocation-id><pub-id pub-id-type="doi">10.1093/sleep/zsx022</pub-id><pub-id pub-id-type="pmid">28204724</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Paulovich</surname> <given-names>A</given-names></name><name><surname>Pomeroy</surname> <given-names>SL</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hidden health crisis costing america billions: underdiagnosing and undertreating obstructive sleep apnea draining healthcare system</article-title><source>Journal of Clinical Sleep Medicine</source><volume>1</volume><fpage>1</fpage><lpage>25</lpage></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Tabula Muris Consortium</collab><collab>Overall coordination</collab><collab>Logistical coordination</collab><collab>Organ collection and processing</collab><collab>Library preparation and sequencing</collab><collab>Computational data analysis</collab><collab>Cell type annotation</collab><collab>Writing group</collab><collab>Supplemental text writing group</collab><collab>Principal investigators</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptomics of 20 mouse organs creates a tabula muris</article-title><source>Nature</source><volume>562</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0590-4</pub-id><pub-id pub-id-type="pmid">30283141</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taipale</surname> <given-names>J</given-names></name><name><surname>Keski-Oja</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Growth factors in the extracellular matrix</article-title><source>The FASEB Journal</source><volume>11</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1096/fasebj.11.1.9034166</pub-id><pub-id pub-id-type="pmid">9034166</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauman</surname> <given-names>R</given-names></name><name><surname>Lavie</surname> <given-names>L</given-names></name><name><surname>Greenfeld</surname> <given-names>M</given-names></name><name><surname>Sivan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Oxidative stress in children with obstructive sleep apnea syndrome</article-title><source>Journal of Clinical Sleep Medicine</source><volume>10</volume><fpage>677</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.5664/jcsm.3800</pub-id><pub-id pub-id-type="pmid">24932149</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>CT</given-names></name><name><surname>Doherty</surname> <given-names>G</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name><name><surname>Cummins</surname> <given-names>EP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hypoxia-dependent regulation of inflammatory pathways in immune cells</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>3716</fpage><lpage>3724</lpage><pub-id pub-id-type="doi">10.1172/JCI84433</pub-id><pub-id pub-id-type="pmid">27454299</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>BL</given-names></name><name><surname>Zhulin</surname> <given-names>IB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>PAS domains: internal sensors of oxygen, redox potential, and light</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>63</volume><fpage>479</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1128/MMBR.63.2.479-506.1999</pub-id><pub-id pub-id-type="pmid">10357859</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Travaglini</surname> <given-names>KJ</given-names></name><name><surname>Nabhan</surname> <given-names>AN</given-names></name><name><surname>Penland</surname> <given-names>L</given-names></name><name><surname>Sinha</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A molecular cell atlas of the human lung from single cell RNA sequencing</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/742320</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trzepizur</surname> <given-names>W</given-names></name><name><surname>Cortese</surname> <given-names>R</given-names></name><name><surname>Gozal</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues</article-title><source>Metabolism</source><volume>84</volume><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2017.11.008</pub-id><pub-id pub-id-type="pmid">29154950</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuder</surname> <given-names>RM</given-names></name><name><surname>Voelkel</surname> <given-names>NF</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Angiogenesis and pulmonary hypertension: a unique process in a unique disease</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>4</volume><fpage>833</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1089/152308602760598990</pub-id><pub-id pub-id-type="pmid">12470512</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuleta</surname> <given-names>I</given-names></name><name><surname>Stöckigt</surname> <given-names>F</given-names></name><name><surname>Juergens</surname> <given-names>UR</given-names></name><name><surname>Pizarro</surname> <given-names>C</given-names></name><name><surname>Schrickel</surname> <given-names>JW</given-names></name><name><surname>Kristiansen</surname> <given-names>G</given-names></name><name><surname>Nickenig</surname> <given-names>G</given-names></name><name><surname>Skowasch</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/Antiprotease system</article-title><source>Lung</source><volume>194</volume><fpage>1015</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1007/s00408-016-9946-4</pub-id><pub-id pub-id-type="pmid">27738828</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valham</surname> <given-names>F</given-names></name><name><surname>Mooe</surname> <given-names>T</given-names></name><name><surname>Rabben</surname> <given-names>T</given-names></name><name><surname>Stenlund</surname> <given-names>H</given-names></name><name><surname>Wiklund</surname> <given-names>U</given-names></name><name><surname>Franklin</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up</article-title><source>Circulation</source><volume>118</volume><fpage>955</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.783290</pub-id><pub-id pub-id-type="pmid">18697817</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Haegebarth</surname> <given-names>A</given-names></name><name><surname>Kujala</surname> <given-names>P</given-names></name><name><surname>Itzkovitz</surname> <given-names>S</given-names></name><name><surname>Koo</surname> <given-names>BK</given-names></name><name><surname>Boj</surname> <given-names>SF</given-names></name><name><surname>Korving</surname> <given-names>J</given-names></name><name><surname>van den Born</surname> <given-names>M</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name><name><surname>Robine</surname> <given-names>S</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A critical role for the wnt effector Tcf4 in adult intestinal homeostatic Self-Renewal</article-title><source>Molecular and Cellular Biology</source><volume>32</volume><fpage>1918</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1128/MCB.06288-11</pub-id><pub-id pub-id-type="pmid">22393260</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vento-Tormo</surname> <given-names>R</given-names></name><name><surname>Efremova</surname> <given-names>M</given-names></name><name><surname>Botting</surname> <given-names>RA</given-names></name><name><surname>Turco</surname> <given-names>MY</given-names></name><name><surname>Vento-Tormo</surname> <given-names>M</given-names></name><name><surname>Meyer</surname> <given-names>KB</given-names></name><name><surname>Park</surname> <given-names>JE</given-names></name><name><surname>Stephenson</surname> <given-names>E</given-names></name><name><surname>Polański</surname> <given-names>K</given-names></name><name><surname>Goncalves</surname> <given-names>A</given-names></name><name><surname>Gardner</surname> <given-names>L</given-names></name><name><surname>Holmqvist</surname> <given-names>S</given-names></name><name><surname>Henriksson</surname> <given-names>J</given-names></name><name><surname>Zou</surname> <given-names>A</given-names></name><name><surname>Sharkey</surname> <given-names>AM</given-names></name><name><surname>Millar</surname> <given-names>B</given-names></name><name><surname>Innes</surname> <given-names>B</given-names></name><name><surname>Wood</surname> <given-names>L</given-names></name><name><surname>Wilbrey-Clark</surname> <given-names>A</given-names></name><name><surname>Payne</surname> <given-names>RP</given-names></name><name><surname>Ivarsson</surname> <given-names>MA</given-names></name><name><surname>Lisgo</surname> <given-names>S</given-names></name><name><surname>Filby</surname> <given-names>A</given-names></name><name><surname>Rowitch</surname> <given-names>DH</given-names></name><name><surname>Bulmer</surname> <given-names>JN</given-names></name><name><surname>Wright</surname> <given-names>GJ</given-names></name><name><surname>Stubbington</surname> <given-names>MJT</given-names></name><name><surname>Haniffa</surname> <given-names>M</given-names></name><name><surname>Moffett</surname> <given-names>A</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell reconstruction of the early maternal-fetal interface in humans</article-title><source>Nature</source><volume>563</volume><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0698-6</pub-id><pub-id pub-id-type="pmid">30429548</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Allmen</surname> <given-names>DC</given-names></name><name><surname>Francey</surname> <given-names>LJ</given-names></name><name><surname>Rogers</surname> <given-names>GM</given-names></name><name><surname>Ruben</surname> <given-names>MD</given-names></name><name><surname>Cohen</surname> <given-names>AP</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Schmidt</surname> <given-names>RE</given-names></name><name><surname>Ishman</surname> <given-names>SL</given-names></name><name><surname>Amin</surname> <given-names>RS</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Smith</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Circadian dysregulation: the next frontier in obstructive sleep apnea research</article-title><source>Otolaryngology--Head and Neck Surgery </source><volume>159</volume><fpage>948</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1177/0194599818797311</pub-id><pub-id pub-id-type="pmid">30200807</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walmsley</surname> <given-names>SR</given-names></name><name><surname>Print</surname> <given-names>C</given-names></name><name><surname>Farahi</surname> <given-names>N</given-names></name><name><surname>Peyssonnaux</surname> <given-names>C</given-names></name><name><surname>Johnson</surname> <given-names>RS</given-names></name><name><surname>Cramer</surname> <given-names>T</given-names></name><name><surname>Sobolewski</surname> <given-names>A</given-names></name><name><surname>Condliffe</surname> <given-names>AM</given-names></name><name><surname>Cowburn</surname> <given-names>AS</given-names></name><name><surname>Johnson</surname> <given-names>N</given-names></name><name><surname>Chilvers</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity</article-title><source>Journal of Experimental Medicine</source><volume>201</volume><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1084/jem.20040624</pub-id><pub-id pub-id-type="pmid">15630139</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname> <given-names>DS</given-names></name><name><surname>Knox</surname> <given-names>C</given-names></name><name><surname>Guo</surname> <given-names>AC</given-names></name><name><surname>Cheng</surname> <given-names>D</given-names></name><name><surname>Shrivastava</surname> <given-names>S</given-names></name><name><surname>Tzur</surname> <given-names>D</given-names></name><name><surname>Gautam</surname> <given-names>B</given-names></name><name><surname>Hassanali</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>DrugBank: a knowledgebase for drugs, drug actions and drug targets</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>D901</fpage><lpage>D906</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm958</pub-id><pub-id pub-id-type="pmid">18048412</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohlrab</surname> <given-names>P</given-names></name><name><surname>Soto-Gonzales</surname> <given-names>L</given-names></name><name><surname>Benesch</surname> <given-names>T</given-names></name><name><surname>Winter</surname> <given-names>MP</given-names></name><name><surname>Lang</surname> <given-names>IM</given-names></name><name><surname>Markstaller</surname> <given-names>K</given-names></name><name><surname>Tretter</surname> <given-names>V</given-names></name><name><surname>Klein</surname> <given-names>KU</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intermittent hypoxia activates Duration-Dependent protective and injurious mechanisms in mouse lung endothelial cells</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1754</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01754</pub-id><pub-id pub-id-type="pmid">30574096</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Tang</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>N</given-names></name><name><surname>Xiong</surname> <given-names>W</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Qi</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reciprocal regulation between the circadian clock and hypoxia signaling at the genome level in mammals</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.009</pub-id><pub-id pub-id-type="pmid">27773697</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Mizuno</surname> <given-names>T</given-names></name><name><surname>Sridharan</surname> <given-names>A</given-names></name><name><surname>Du</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Wikenheiser-Brokamp</surname> <given-names>KA</given-names></name><name><surname>Perl</surname> <given-names>AT</given-names></name><name><surname>Funari</surname> <given-names>VA</given-names></name><name><surname>Gokey</surname> <given-names>JJ</given-names></name><name><surname>Stripp</surname> <given-names>BR</given-names></name><name><surname>Whitsett</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis</article-title><source>JCI Insight</source><volume>1</volume><elocation-id>e90558</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.90558</pub-id><pub-id pub-id-type="pmid">27942595</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>MY</given-names></name><name><surname>Lin</surname> <given-names>PW</given-names></name><name><surname>Lin</surname> <given-names>HC</given-names></name><name><surname>Lin</surname> <given-names>PM</given-names></name><name><surname>Chen</surname> <given-names>IY</given-names></name><name><surname>Friedman</surname> <given-names>M</given-names></name><name><surname>Hung</surname> <given-names>CF</given-names></name><name><surname>Salapatas</surname> <given-names>AM</given-names></name><name><surname>Lin</surname> <given-names>MC</given-names></name><name><surname>Lin</surname> <given-names>SF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Alternations of circadian clock genes expression and oscillation in obstructive sleep apnea</article-title><source>Journal of Clinical Medicine</source><volume>8</volume><elocation-id>1634</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8101634</pub-id><pub-id pub-id-type="pmid">31590444</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yehualaeshet</surname> <given-names>T</given-names></name><name><surname>O'Connor</surname> <given-names>R</given-names></name><name><surname>Begleiter</surname> <given-names>A</given-names></name><name><surname>Murphy-Ullrich</surname> <given-names>JE</given-names></name><name><surname>Silverstein</surname> <given-names>R</given-names></name><name><surname>Khalil</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>23</volume><fpage>204</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.23.2.4089</pub-id><pub-id pub-id-type="pmid">10919987</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Qin</surname> <given-names>Y</given-names></name><name><surname>Bo</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>GOSemSim: an R package for measuring semantic similarity among GO terms and gene products</article-title><source>Bioinformatics</source><volume>26</volume><fpage>976</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq064</pub-id><pub-id pub-id-type="pmid">20179076</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zambon</surname> <given-names>AC</given-names></name><name><surname>Gaj</surname> <given-names>S</given-names></name><name><surname>Ho</surname> <given-names>I</given-names></name><name><surname>Hanspers</surname> <given-names>K</given-names></name><name><surname>Vranizan</surname> <given-names>K</given-names></name><name><surname>Evelo</surname> <given-names>CT</given-names></name><name><surname>Conklin</surname> <given-names>BR</given-names></name><name><surname>Pico</surname> <given-names>AR</given-names></name><name><surname>Salomonis</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>GO-Elite: a flexible solution for pathway and ontology over-representation</article-title><source>Bioinformatics</source><volume>28</volume><fpage>2209</fpage><lpage>2210</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts366</pub-id><pub-id pub-id-type="pmid">22743224</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>MJ</given-names></name><name><surname>Ntranos</surname> <given-names>V</given-names></name><name><surname>Tse</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>One read per cell per gene is optimal for Single-Cell RNA-Seq</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/389296</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Hunter</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Maidstone</surname> <given-names>R</given-names></name><name><surname>Mizoro</surname> <given-names>Y</given-names></name><name><surname>Vonslow</surname> <given-names>R</given-names></name><name><surname>Fife</surname> <given-names>M</given-names></name><name><surname>Hopwood</surname> <given-names>T</given-names></name><name><surname>Begley</surname> <given-names>N</given-names></name><name><surname>Saer</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Cunningham</surname> <given-names>P</given-names></name><name><surname>Baxter</surname> <given-names>M</given-names></name><name><surname>Durrington</surname> <given-names>H</given-names></name><name><surname>Blaikley</surname> <given-names>JF</given-names></name><name><surname>Hussell</surname> <given-names>T</given-names></name><name><surname>Rattray</surname> <given-names>M</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Gibbs</surname> <given-names>J</given-names></name><name><surname>Ray</surname> <given-names>DW</given-names></name><name><surname>Loudon</surname> <given-names>ASI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide effect of pulmonary airway epithelial cell-specific <italic>Bmal1</italic> deletion</article-title><source>FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology</source><volume>33</volume><fpage>6226</fpage><lpage>6238</lpage><pub-id pub-id-type="doi">10.1096/fj.201801682R</pub-id><pub-id pub-id-type="pmid">30794439</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>YD</given-names></name><name><surname>Barnard</surname> <given-names>M</given-names></name><name><surname>Tian</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Ring</surname> <given-names>HZ</given-names></name><name><surname>Francke</surname> <given-names>U</given-names></name><name><surname>Shelton</surname> <given-names>J</given-names></name><name><surname>Richardson</surname> <given-names>J</given-names></name><name><surname>Russell</surname> <given-names>DW</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system</article-title><source>PNAS</source><volume>94</volume><fpage>713</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.2.713</pub-id><pub-id pub-id-type="pmid">9012850</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilionis</surname> <given-names>R</given-names></name><name><surname>Engblom</surname> <given-names>C</given-names></name><name><surname>Pfirschke</surname> <given-names>C</given-names></name><name><surname>Savova</surname> <given-names>V</given-names></name><name><surname>Zemmour</surname> <given-names>D</given-names></name><name><surname>Saatcioglu</surname> <given-names>HD</given-names></name><name><surname>Krishnan</surname> <given-names>I</given-names></name><name><surname>Maroni</surname> <given-names>G</given-names></name><name><surname>Meyerovitz</surname> <given-names>CV</given-names></name><name><surname>Kerwin</surname> <given-names>CM</given-names></name><name><surname>Choi</surname> <given-names>S</given-names></name><name><surname>Richards</surname> <given-names>WG</given-names></name><name><surname>De Rienzo</surname> <given-names>A</given-names></name><name><surname>Tenen</surname> <given-names>DG</given-names></name><name><surname>Bueno</surname> <given-names>R</given-names></name><name><surname>Levantini</surname> <given-names>E</given-names></name><name><surname>Pittet</surname> <given-names>MJ</given-names></name><name><surname>Klein</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species</article-title><source>Immunity</source><volume>50</volume><fpage>1317</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.009</pub-id><pub-id pub-id-type="pmid">30979687</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63003.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Agrawal</surname><given-names>Anurag</given-names></name><role>Reviewing Editor</role><aff><institution>CSIR Institute of Genomics and Integrative Biology</institution><country>India</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Agrawal</surname><given-names>Anurag</given-names> </name><role>Reviewer</role><aff><institution>CSIR Institute of Genomics and Integrative Biology</institution><country>India</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Mabalirajan</surname><given-names>U</given-names> </name><role>Reviewer</role><aff><institution>IICB</institution><country>India</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Obstructive sleep apnea is an important medical problem, with elevated cardiovascular risk as a common association. Intermittent hypoxic episodes are a good predictor of such risk. The authors use single cell genomics to delineate the changes in various lung cell types in intermittent hypoxia models, with potential mechanistic insights that are translatable to OSA and other lung diseases with hypoxia as a core component.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Short-term exposure to intermittent hypoxia leads to changes in gene expression seen in chronic pulmonary disease&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Anurag Agrawal as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Matt Kaeberlein as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: U Mabalirajan (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>Obstructive sleep apnea is an important medical problem, with elevated cardiovascular risk as a common association. Intermittent hypoxic episodes are a good predictor of such risk so a connection is indeed plausible. The authors use single cell genomics to delineate the changes in intermittent hypoxia models, with interesting insights, but what limits enthusiasm is validation of some hypothesis generating findings from single cell data, limiting potential mechanistic insights that are translatable to OSA</p><p>Essential revisions:</p><p>1) Since intermittent hypoxia is not identical to OSA but is a potentially useful model, the first group of essential revisions pertains to new analysis of your existing data.</p><p>a) Relevance of gene expression findings should be verified in available public data and compared to publications.</p><p>b) Compensatory mechanisms for hypoxia, including angiogenesis, are expected but produce little insight unless placed in context of disease processes relevant to OSA.</p><p>c) Whether the gene expression change can be explained by changes in cell numbers should be clearly explained. Given the complexity of information obtained, I think it warrants a more detailed analysis. It would be helpful if the authors could distil the very large volumes of information into a more extensive discussion of their findings (particularly discussing the figures in more detail).</p><p>d) Morphometry should be used in histological studies</p><p>2) Additional data is needed to increase confidence in reported findings:</p><p>a) Cell types with gross alterations should be specifically checked, including by quantitative sorting and population analysis with additional markers, to ensure cell type specificity.</p><p>b) The changes in myofibroblasts is unexpected and interesting. This needs specific verification and deeper explanation. While it is known that single cell sequencing had indicated the possible presence of new cell types, it should not ignore the already well known cell types.</p><p>c) It is really surprising to see the predominant presence of endothelial cells. This is different from available literature based on single cell sequencing based molecular cell atlas. In general, <italic>Sox17</italic>, a marker of endoderm, is also expressed by other endoderm derived derivatives like epithelia. (Park et al., Am J Respir Cell Mol Biol. 2006 Feb;34(2):151-7). Amine oxidase C3 is relatively new marker of myofibroblasts (Hsia et al., Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2162-71). But this ectoenzyme also expressed abundantly in adipocytes, endothelial cell and other cells.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63003.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Since intermittent hypoxia is not identical to OSA but is a potentially useful model, the first group of essential revisions pertains to new analysis of your existing data.</p><p>a) Relevance of gene expression findings should be verified in available public data and compared to publications.</p></disp-quote><p>We agree with the reviewers. In addition to our original analyses, we have comprehensively compared gene expression findings to additional publications described in the revised manuscript. Please see the section entitled, “Pulmonary disease-regulated genes provide clinical implications for OSA at the cell-specific level” in the Results for details (see citations and links for websites).</p><disp-quote content-type="editor-comment"><p>b) Compensatory mechanisms for hypoxia, including angiogenesis, are expected but produce little insight unless placed in context of disease processes relevant to OSA.</p></disp-quote><p>We agree with the reviewers and have revised our manuscript throughout. For example, we added context for angiogenesis in the setting of OSA in the Results section titled, “Short-term exposure to intermittent hypoxia reshapes circadian and immune pathways in the lung.” We also expanded our description of down-regulated pathways and correlated these to OSA. For example, we expanded the section on immune response in OSA and associated changes after CPAP treatment in the Results section titled, “Diverse expression pathways were up and downregulated in the presence of intermittent hypoxia.”</p><disp-quote content-type="editor-comment"><p>c) Whether the gene expression change can be explained by changes in cell numbers should be clearly explained.</p></disp-quote><p>The reviewers raise an important point. Here, we verified that changes in cell numbers do not influence gene expression by 3 approaches:</p><p>1) We present bulk RNA-seq data in the manuscript. Our trend in circadian and immune pathways, for example, is the same for bulk RNA-seq (compared to the scRNA-seq data). This confirms that these trends are the same using different techniques and completely different procedures.</p><p>2)In our original analysis, we normalized the data to minimize the effects of changes in cell number on gene expression. We added information in the Results to clarify this point; listed under the section, “Diverse expression pathways were up and down regulated in the presence of intermittent hypoxia.”</p><p>3) In addition, we randomly down-sampled an equal number of cells for each cell type from the control and IH groups. The down-sampling process was performed 10 times per cell type. The fold change values of the top 200 up and down regulated genes was consistent with the fold change when using all cells from each population. As shown in <xref ref-type="fig" rid="respfig1">Author response image 1</xref>, there is a clear linear relationship of gene expression changes between using all cells and an equal number of endothelial (Endo), myofibroblast (MyoFB), AT2, macrophage (Mphage), natural killer (NK), and B cells.</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63003-resp-fig1-v3.tif"/></fig><disp-quote content-type="editor-comment"><p>Given the complexity of information obtained, I think it warrants a more detailed analysis. It would be helpful if the authors could distil the very large volumes of information into a more extensive discussion of their findings (particularly discussing the figures in more detail).</p></disp-quote><p>We expanded our Results section to provide more information, with “Diverse expression pathways were up and downregulated in the presence of intermittent hypoxia,” “Pulmonary vascular endothelial subpopulations show distinctive responses to intermittent hypoxia,” and “Pulmonary disease-regulated genes provide clinical implications for OSA at the cell-specific level.”</p><disp-quote content-type="editor-comment"><p>d) Morphometry should be used in histological studies</p></disp-quote><p>We added cell counts to the text and figures (Figure 3—figure supplement 1) and a more detailed analysis of morphometry (e.g. alveolar area and alveolar wall thickness; Figure 3—figure supplement 2). We did not see comprehensive changes in alveolar area and alveolar wall thickness based on morphometry quantification for mice exposed to IH compared to controls (Figure 3—figure supplement 2). Please see the revised Results section titled, “Short-term exposure to intermittent hypoxia did not lead to comprehensive histologic changes in the lung.” Additionally, we expanded on this in the Discussion.</p><disp-quote content-type="editor-comment"><p>2) Additional data is needed to increase confidence in reported findings:</p><p>a) Cell types with gross alterations should be specifically checked, including by quantitative sorting and population analysis with additional markers, to ensure cell type specificity.</p></disp-quote><p>We agree and have expanded our description of the techniques to confirm cell types.</p><p>1) For clarification, we used 40-60 AltAnalyze selected markers in each cluster and annotated each cluster to a known cell type based on a comprehensive lung cell marker reference gene list collected from publicly available databases (e.g. Mouse Cell Atlas, ToppGene and LGEA) and published lung scRNA-seq data. See the following references for examples of the publicly available data:</p><p>a) Consortium et al., 2018.</p><p>b) Chen et al., 2009.</p><p>c) Du et al., 2017.</p><p>d) Cohen M et al., 2018, Cell 175(4):1031-1044.e18.</p><p>e) Zilionis et al., 2019.</p><p>2) We also used two canonical markers for each cell type for confirming the cell type specificity (revised Figure 2C). We further clarified the steps of ensuring cell-type specificity in the revised manuscript. Overall, the technique for determining cell type from scRNA-seq data from the lung is well-established (Salomonis N et al., 2019, Methods Mol Biol 1975:251-275; Guo et al., 2019).</p><p>3) We have quantified differences in cell numbers (with statistical analyses) for specific cell populations in the lung from mice exposed to IH versus controls. Specifically, we stained for and quantified those specific cell types with “gross alterations” from the scRNA-seq data (Figure 3—figure supplement 1). These data have been added to the Results, under the section titled, “Short-term exposure to intermittent hypoxia did not lead to comprehensive histologic changes in the lung.” Based on our expanded analytic techniques, as the reviewers recommended, and the additional cell counts, we are confident that our findings concerning the alterations in the proportion of cell types are accurate.</p><disp-quote content-type="editor-comment"><p>b) The changes in myofibroblasts is unexpected and interesting. This needs specific verification and deeper explanation. While it is known that single cell sequencing had indicated the possible presence of new cell types, it should not ignore the already well known cell types.</p></disp-quote><p>We agree. We performed a GSEA enrichment analysis for all of the detected genes from myofibroblasts and have revised and added several supplementary figures (Figure 6—figure supplements 4 and 5).We expanded our findings in the Results section titled, “Pulmonary disease-regulated genes provide clinical implications for OSA at the cell-specific level,” as well as in the Discussion.</p><disp-quote content-type="editor-comment"><p>c) It is really surprising to see the predominant presence of endothelial cells. This is different from available literature based on single cell sequencing based molecular cell atlas. In general, Sox17, a marker of endoderm, is also expressed by other endoderm derived derivatives like epithelia. (Park et al., Am J Respir Cell Mol Biol. 2006 Feb;34(2):151-7). Amine oxidase C3 is relatively new marker of myofibroblasts (Hsia et al., Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2162-71). But this ectoenzyme also expressed abundantly in adipocytes, endothelial cell and other cells.</p></disp-quote><p>On average, 28.8% of our detected cells using scRNA-seq are endothelial cells in control mice (Figure 2—figure supplement 1). This is very similar to the percentage of endothelial cells (26.7%) reported in the recently published human lung atlas paper (Kyle J Travaglini et al. Nature 2020 Nov;587(7835):619).</p><p>In our revised figure (Figure 2C), we added Tek, along with <italic>Sox17</italic>, as an additional canonical endothelial marker gene. Additionally, we used <italic>Aspn</italic> and <italic>Acta2</italic> instead of <italic>Aoc3</italic> as canonical myofibroblast marker genes. Despite these modifications, the percentage of endothelial cells was unchanged, confirming the specificity of our cell population. We further clarified our cell identification technique (as described in reviewer comment 2a above). This has been added to the Results section. As the reviewer points out, there is a dual lineage-specific expression of <italic>Sox17</italic> during mouse embryogenesis (Choi E et al. Stem Cells 2012 30(10):2297). In the lung, <italic>Sox17</italic> is expressed in mesenchymal progenitors of the embryonic pulmonary vasculature and is restricted to vascular endothelial cells in the mature lung (Lange AW et al. Developmental Biology 387 (2014) 109-120).</p></body></sub-article></article>